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1 Introduction 
Cancer is the leading cause of death in developed countries and has long 
surpassed cardio-vascular diseases. Meanwhile it is also the second leading 
cause of death in developing countries. Also, incidence and mortality seem 
to be rising. Back in 2002, 10.9 million new cases of cancer and 6.7 million 
deaths related to cancer were reported(1). In 2008 however, about 12.7 
million cases and 7.6 million deaths related to cancer are estimated to have 
occurred worldwide(2, 3). While incidence rates in developed countries are 
almost twice as high as in developing countries in men (77% higher) and 
women (57% higher), mortality is only slightly higher in men (18% higher) 
and women (1% higher)(2). This reflects diagnosis in earlier stages of the 
disease as well as availability and use of treatment services. 
Oral and pharyngeal cancer is the sixth most common cancer in the world. 
Worldwide, 275,000 new cases from oral cavity cancer and 130,300 new 
cases of oropharyngeal cancer occurred in 2008. Incidence of these forms of 
cancer varies widely between geographic regions, which is attributable to the 
risk factors prevalent in these regions(4).  
In 2008, 91,900 new cases with oral and pharyngeal cancer could be found 
in Europe, 68,100 male and 23,800 female patients, making oral and 
pharyngeal cancer the seventh leading cancer in Europe. Overall mortality in 
2008 was 41,700 (32,900 male and 8,800 female)(5). 
For men, age standardized rates (ASR) of cancer incidence are generally 
higher in Central and Eastern Europe (19.7/100,000) than in Western 
(18.9/100,000) and Southern Europe (16.8/100,000). The lowest regional 
incidence rates were found in Northern Europe (12.0/100,000).  
In women, the highest regional incidence rates are found in Western 
(5.9/100,000) and Northern Europe (5.3/100,000). Southern (4.5/100,000) 
und Central and Eastern Europe (3.6/100.000) report lower rates.  
Alike for men and women, of all countries in the EU, Cyprus (4.3/100,000 
men, 1.5/100,000 women) and Greece (6.8/100,000 men, 2.0/100,000 
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women) showed the lowest incidence of oral cancer, while the highest rate 
of new cases occurred in Hungary (46.1/100,000 men, 10.3/100,000 
women)(5). 
In Germany, 11,390 new cases (8,320 male and 3,070 female) were 
estimated in 2008 and 4,640 patients died of oral cancer (3,570 male and 
1,070 female)(5). 
Over 90% of malignancies in the upper aerodigestive tract are squamous 
cell carcinomas(4) (SSC) and have the same risk factors as the other head 
and neck carcinomas. Risk factors include consumption of alcohol and 
tobacco(6, 7), but only recently an association to Human Papilloma Virus 
(HPV) infections has been found(8). The remaining malignancies form a 
heterogeneous group consisting mostly of salivary gland tumours, sarcomas 
of soft tissue and the jaw bones as well as melanomas. In rare cases, 
lymphoreticular malignancies, malignant odontogenic tumours and 
metastases from non-oral cancers can be found. 
Like other malignancies, oral squamous cell carcinomas are classified 
according to the tumour-node-metastasis (TNM) staging system of UICC 
(Union for International Cancer Control). The TNM classification simply 
describes the cancers anatomical extend of the tumour at its primary site (T 
stage), the regional lymph nodes (N stage) and existence or absence of 
remote metastases (M stage)(9). Derived from the TNM stages, cancer can 
be classified by certain UICC stages ranging from I to IV which are directly 
related to prognosis. A higher UICC stage means a worse overall prognosis 
and therefore usually leads to a more radical treatment.  
The overall five-year survival rate for oral cancer is around 50%(8). While 
UICC stage I oral cancer has a 5-year-survival rate of up to 80%, it is 
dramatically lower in patients who present themselves with advanced 
disease (UICC stage III/IV) and may drop to as low as 20%(4). 
A basic principle of the treatment of oral cancer is to achieve permanent or 
longest possible locoregional control of the tumour. In the head and neck, 
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standard resection margins of 1-3cm usually desired in oncologic surgery are 
not always feasible. Because of the limited options for resection, loco-
regional recurrence as well as metastasis to regional lymph nodes is 
relatively frequent in aggressive cancers and leads to poor survival rates(10). 
Historically, ablative and extirpative surgery was the primary and only 
means for curative intention. Lately, chemotherapy and radiation therapy 
play an equally important role in the treatment concepts. For some cases, a 
targeted therapy might be a viable option. While the smaller defects 
corresponding with lower UICC stages can be often curatively treated with 
surgery or radiotherapy as a single modality, more advanced stages require 
a multimodal approach often making use of a combination of surgical 
treatment and postoperative radiotherapy and/or chemotherapy.  
Depending on the localization of the tumour, radical surgical treatment can 
lead to a variety of impairments, the most common of which are 
disfigurement and severe impact on speech, swallowing and chewing. 
Serious disabilities lead to nutritional deficits - themselves associated with 
wound healing disorders - and possibly prolonged need of parenteral 
nutrition or feeding tubes. Disfigurement and inability to speak might lead to 
social deprivation and isolation leading to depression.  
These dysfunctions can be due to primary resection of the involved and 
functionally unique tissues, when they have been infiltrated by the tumour, 
or be long-term complications like formation of fistulas or fibrosis and neural 
impairment often encountered after radiotherapy(11, 12). Treatment of oral 
cancer and the collateral damages involved is therefore very complex and 
should be approached by a multi-profession team. 
Two concepts are of major importance in regard to long-term outcome: The 
first and foremost aim must be the eradication of the disease often requiring 
extreme ablative or extirpative procedures. In the long run, late effects and 
control of the possible complications play an evenly important role and often 
have tremendous impact on quality of life which can be measured by scales 
like the Karnowsky Index, Functional Living Index(13) or ICF (International 
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Classification of Function)(14, 15). The best possible reconstruction is desirable 
to regain a high level of function.  
In reconstruction of the head and neck, restoration of integrity of the face, 
neck and alimentary tract takes highest priority to prevent fistula formation 
as well as life-threatening conditions like carotid artery blow-out. Next, 
restoration of functions like swallowing, mastication, facial expression and 
speech should be attempted. Last but not least restoring form in an 
aesthetically pleasing way should be considered, if the general condition of 
the patient allows(16).  
Plastic and reconstructive surgery has come to use a plethora of different 
flaps, divided in pedicled and free microvascular flaps. While the first often 
offer better perfusion and shortened operative time in co-morbid patients 
and may often be better suited to previously irradiated patients, the later 
promise optimal results for recovery of function due to better tissue 
reconstruction(17, 18). In 1957, Seidenberg et al. performed the first auto-
transplanted heterotypical tissue transfer in a human patient, when they 
transplanted a jejunal segment for reconstruction of the cervical oesophagus 
using a small vessel anastomotic technique and started the development of 
many different free flaps frequently used nowadays(19). 
Through improved techniques in surgery and anaesthesiology longer and 
more complex procedures evolved allowing for simultaneous ablative and 
reconstructive surgery. Both pedicled and free flaps have been used that 
way commonly and successfully for decades. For reconstruction of the head 
and neck the use of free flaps has been the means of choice for almost 20 
years as they are more flexible than pedicled flaps(20). It is clear, that the 
free radial forearm flap (fRFF) is considered the “workhorse” of 
reconstructive surgery in the head and neck region due to its stable blood 
supply, long pedicle length and the relative ease to achieve moulding to 
complex geometrical structures. It is used in 55-70% of all soft tissue 
transfers in the head and neck. Other commonly used fasciocutaneous free 
flaps are the rectus abdominis (10-15%) and anterolateral thigh flap (4-
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8%). Each of this flaps has advantages and disadvantages and is used to 
meet the demands of the recipient site(21). Still, there are many more types 
of highly specialized flaps available - like the free ileocolon flap used for 
speech rehabilitation(22). 
Free flap transfer and microsurgery have become two of the fastest growing 
fields in head and neck surgery over the last two decades as more 
sophisticated methods of surgical tumour treatment evolved and the need to 
cover the defects and restore integrity and functionality arose. Nowadays 
most academic otolaryngology or head and neck surgical units employ at 
least one microsurgeon and this number seems to be raising still(23).  
Success rates for free flap transfer are being reported from 95-99% percent 
for the most experienced centers with reexplorations needed in 6-14% of 
the cases(24, 25). Salvage rates range from 33-81% and the vast majority of 
anastomosis related problems, up to 95.6%, occur within the first 72 
postooperative hours(25). Flap failures almost exclusively run back to 
vascular problems like impeded arterial inflow or venous outflow obstruction. 
In this time window, surgical reexploration goes along with high salvage 
rates, but must rely on the right clinical judgement beforehand to take the 
patient back to the operating theatre. To not risk flap survival, a very low 
threshold for reoperation is to be maintained, so that even the slightest hint 
of vascular compromise is taken seriously and eventually leads to revision. 
Logically, this can lead to unnecessary procedures that may endanger the 
patient and are costly as well, so they should be avoided if possible. 
When so called buried flaps with no or minimal surface exposure are used, 
or the recipient site is usually inaccessible like in the hypopharynx, sufficient 
monitoring might be hard to achieve. One technique often applied in these 
cases is the use of a so called "monitor flap", a special externalized portion 
of the distal flap that is sewn in on skin level and facilitates clinical 
examination and is supposed to be indicative of the perfusion state of the 
buried portion of the flap(26-29). 
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A good monitoring method should be safe, mobile, reliable, easy to use and 
interpret and be able to immediately detect vascular compromise. Ideally, it 
should differentiate between venous and arterial problems. Although many 
different invasive and non-invasive monitoring techniques for free-flaps have 
been described, it is still to be proven whether any of these new methods 
brings any advantage over clinical judgment by an experienced surgeon(30). 
In times of global economic crisis, a look at the costs should also be taken 
into consideration. 
To date, clinical judgment is the most important source of information. 
Although most centers acknowledge, that the first 72 postoperative hours 
are crucial for flap survival, monitoring regimes vary greatly between these 
institutions from hourly checks for the first 72 hours in a controlled setting 
like an intensive care unit (ICU) or intermediate care unit (IMC) to daily 
checks and early discharge from hospital. Also, most centers use hand-held, 
transcutaneous Doppler-probes to assess arterial and venous flow in the 
pedicle vessels(23, 31). Another way to assess perfusion is to do it optically. 
There are a different approaches to this, usually using fluorescent dyes like 
Fluoresceine or Indocyanine Green (ICG).  
Fluorescence is a form of luminescence and describes the emission of light 
by a substance, which has previously absorbed energy either in form of 
photons (light) or electromagnetic radiation. An electron, orbiting a 
molecule, is excited to a higher quantum state by absorbing some kind of 
energy. When the electron falls back or relaxes to its former lower quantum 
state, the formerly absorbed energy is emitted. By definition, the emitted 
light has a longer wavelength and therefore lower energy than the absorbed 
radiation, which is called a Stokes shift. 
Fluorescein angiography is often used in ophthalmology for visualization of 
retinal and choroidal circulation. It evolved in 1961 and is still in clinical use 
on a regular basis(32). In the early 1970s, Flower and Hochheimer started to 
use Indocyanine Green (ICG) angiography in ophthalmology first(33), but 
since then has been refined by adding new technology like the 
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videoangiography and laser scanning ophthalmoscope(34). Later its use has 
spread to other medical fields in need of visualization of circulation and also 
serves to evaluate liver perfusion and function(35). 
In some surgical fields like plastic and reconstructive surgery(36, 37), 
coronary-bypass surgery und neurosurgery(38, 39), Indocyanine Green (ICG)-
fluorescence angiography is already in frequent use for assessing perfusion 
of freshly anastomosed vessels or clipped aneurysms intraoperatively. 
Studies have shown that it corresponds well with bloodflow and is easy to 
use and interpret(40) and is able to predict necrosis in pedicled and free 
flaps(41, 42). 
The presented method of endoscopic ICG-fluorescence-angiography might 
be beneficial in the head and neck area since it can easily adapt to the 
complex three-dimensional geometry and reach otherwise hidden flaps. This 
study was intended to prove the feasibility of the method and to our 
knowledge is the first to employ endoscopic equipment. 
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2 Patients, Material and Methods 
2.1 Patient Recruitment 
According to the study protocol, a total of 25 patients were to be included in 
order to prove the feasibility of the method. Beginning in December 2007 
after the study design had been approved by the ethics committee of the 
LMU, recruitment of the patients started. All patients with a need for free 
flap transplantation into the oral cavity or oropharynx who were admitted to 
the Department of ENT were asked for their participation. The need for 
transplantation may have arisen from either primary resection of the cancer 
or secondary reconstruction after prior resection. All patients who agreed to 
participate in the study were included. There was no further prerequisite 
regarding gender, age, classification or location of cancer or type of flap. The 
participants have been informed of the purpose of the study and probable 
benefits for future patients as well as possible risks of the endoscopic 
examinations and the administration of ICG. They had to give their informed 
consent in written form after a consideration period of at least 24 hours to 
be included. Exclusion criteria primarily derived from the use of ICG and 
consisted of prior adverse anaphylactic or anaphylactoid reaction to ICG, 
severe liver dysfunction and known hypersensitivity to iodide. Newborn 
children and pregnant women were also to be excluded, since appropriate 
data on safety in these patients are lacking. 
2.2 Medication and dosing of Indocyanine green 
2.2.1  Physical and Physiological Properties of Indocyanine green 
Indocyanine green (ICG) is a water-soluble, amphiphilic, tricarbocyanine dye 
(see Figure 1). It has been internationally licensed and used in clinical routine 
for decades for examinations of liver and cardiac function as well as the 
choroideal vasculature. Due to its pharmacokinetic and physical properties, 
ICG can also be used in fluorescence perfusion diagnostics. 
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Figure 1: Indocyanine Green (ICG) - molecular structure 
 
Within two seconds after intravenous injection ICG binds to plasma proteins, 
preferentially α1-lipoproteins. Weak binding to Human Serum Albumin and 
phospholipids has also been reported. Therefore, the diffusion out of the 
healthy vessels and peripheral uptake are negligible. The molecules are then 
rapidly degraded in the liver and through their lipophilic properties 
eliminated via the biliary system, where they are not subject to 
enterohepatic recirculation. These pharmacokinetic properties lead to a 
plasmatic half-life of only 3-4 minutes and allow for the dye to be repeatedly 
injected after 20 minutes. Protein-bound ICG has a characteristic absorption 
maximum of 805nm or 810nm and an emission maximum at 820-830 nm. 
With higher concentration over 80µg/ml, ICG tends to form aggregates. 
Through aggregation the fluorescence yield of the dye decreases, because 
ICG polymers have a weaker fluorescence yield than monomers. This 
process is called quenching(43). 
The used, commercially available preparation of ICG used in this study, “ICG 
Pulsion” (Pulsion Medical Systems AG, Munich, Germany), contains a iodine 
component, that is needed to allow crystallization. Adverse reactions 
including anaphylactic and anaphylactoid reaction have been reported, but 
are very rare (approx. 1:42 000)(44). 
2.2.2  Dosing of ICG 
In this study, ICG was dosed based on the weight of the patients. The dose 
was 0.3mg/kg body weight in all the patients analogously to the 
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recommended dosage for other perfusion examinations using ICG. 25mg of 
ICG dry powder were diluted in 5ml of sterile H2O (aqua), and then the 
appropriate volume of the ready-to-use ICG solution was injected 
intravenously. 
2.2.3  Administration of the Drug 
The dye was administered either via central venous lines through the 
subclavian or jugular vein or – if those were not available – via peripheral 
venous catheters. The appropriate dose was injected in one fast bolus and 
the i.v. system rinsed with at least 10 ml of normal saline solution to ensure 
the rapid rise of plasma ICG levels. 
2.2.4  Provision of ICG 
The required amount of ICG was provided for free by the manufacturer, 
Pulsion Medical Systems AG (Munich, Germany), for exclusive use in the 
study. 
2.3 Technical equipment 
All technical equipment needed was CE-marked and was provided for free 
for exclusive use in the study during the time of the examinations by the 
manufacturer Karl Storz GmbH (Tuttlingen, Germany). Since the primary 
aim of this study was to prove the value of an endoscopic ICG-Angiography 
for assessing the vitality of the flaps, there was a need for close cooperation 
with the manufacturer of the used optical equipment, which lead to further 
refinements of the optical equipment while the examinations and data 
acquisition was still ongoing. As soon as it was available, the next generation 
gear was used. 
2.3.1  Endoscopes 
In the course of the study a total of three different endoscopes in 
comparable configurations were used. After a short initial phase where a 
standard endoscope was used in combination with a snap-on ICG-filter, a 
provisional study endoscope with an integrated ICG-filter was provided by 
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KARL STORZ. The intensive feedback finally led to further refinements on 
the study endoscope and the development of a second generation ICG 
endoscope with improved imaging qualities due to the usage of better 
suited, coated lenses and filter systems. 
• Provisional Karl Storz GmbH Hopkins II endoscope: 
10mm straight forward (0°) endoscope without built-in ICG-Filter and 
thus with a need for an external filter that is snapped between the 
camera and the endoscope (Karl Storz GmbH, Tuttlingen, Germany) 
• Karl Storz GmbH ICG Hopkins Optik 0° endoscope (1st generation): 
 10mm straight-facing (0°) endoscope, 20cm long, (Karl Storz GmbH, 
Tuttlingen, Germany) with build-in switchable ICG-Filter 
• Karl Storz GmbH ICG Hopkins Optik 0° endoscope (2nd generation): 
5,8mm straight forward (0°) endoscope, 19cm long, (Karl Storz 
GmbH, Tuttlingen, Germany) with built-in switchable ICG-Filter and 
improved lenses for better light transmission the NIR wavelength and 
improved antireflection coating  
2.3.2  Observation Filter 
The observation filter was designed to block the excitation light and let only 
ambient light and ICG fluorescence pass and be registered by the camera. 
Therefore wavelengths below 800nm were blocked. It was either integrated 
in the endoscope as a part of a changeable filter block or a separate snap-on 
filter (Aufsteckfilter mit ALA-Filter, Karl Storz GmbH, Tuttlingen, Germany), 
which can be fitted to various endoscopes. 
2.3.3  Light source 
Red/near-infrared (NIR) excitation light at ~740 - 780 nm was emitted by a 
filtered Xenon Short Arc lamp (D-Light, Karl Storz GmbH, Tuttlingen, 
Germany) and transmitted to the endoscope via a standard fluid light guide 
(Fluid-Lichtkabel, 250cm, 5mm, Karl Storz GmbH, Tuttlingen, Germany). 
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2.3.4  Camera and controller 
For imaging of the white light as well as the fluorescence examinations, two 
different NIR sensitive RGB three-chip CCD-endocamera-systems (Karl Storz 
GmbH, Tuttlingen, Germany) which could be set to IR/NIR mode were used 
(Tricam PDD Camera System & Image 1 Camera System, Karl Storz, 
Tuttlingen, Germany). The used camera controller was a routine off-the-
shelf controller (Tricam PDD Control Unit, Karl Storz GmbH, Tuttlingen, 
Germany) that needed no further modification towards the specified use, 
because the IR/NIR signals received by the camera could be interpreted 
without problems.  
A switch on the camera handle was programmed to change the settings of 
the light source and camera simultaneously from white light to fluorescence 
imaging and back again.  
2.3.5  Video and audio recording system 
All data were recorded and stored using an AIDA Compact NEO Standard 
system (Karl Storz GmbH, Tuttlingen, Germany). This allowed for 
simultaneous recording of a video and audio input; as well, it was possible to 
save high resolution still images. The resulting movies were stored in 
compressed mov-video format, single images used the TIFF-format. Both 
movies and still images had a resolution of 720 x 544 pixels. The AIDA 
system’s recording can be managed using the provided pedal switch or the 
standard computer input, mouse and keyboard. 
2.3.6  ICG reference 
To improve the reproducibility, a standardized platelet with ICG dye was 
placed as a reference next to the areas of interest in approximately the 
same distance from the endoscope.  
The ICG reference was made of an ICG-dye stained piece of cloth of 
approximately 1,5 x 1 cm (provided by Pulsion AG), that had been laminated 
in plastic and could be sterilized and reused. While the ICG-standard proved 
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to be fairly resistant to photobleaching, the ideal concentration of the ICG 
dye the cloth was stained with had been experimentally determined during 
the preparation phase of the study.  It was diluted and checked under NIR 
excitation until it the stained cloth was always the most intensely fluorescing 
item in a specified experimental setting without leading to total 
overexposure of the signal by reaching the sensitivity limit of the CCD-chip 
and thus leading to loss of information. To avoid involuntary accidental 
swallowing of the platelet by a conscious patient, a thread was attached to 
it, so it could easily and quickly be recovered if necessary.  
2.3.7 Safety Acknowledgement 
All equipment listed above was mounted in a single mobile video rack and 
was approved for safe usage in the operation room (OR) as well as the 
intensive care units (ICU). The light intensity emitted by the light source was 
set to levels that would not lead to thermal damages when used in the 
intended distance while providing optimal conditions for the fluorescence 
measurements at the same time. 
2.4 Experimental Design 
2.4.1  Usual Procedure After Surgery 
After Surgery, the patients are brought from the OR to the ICU while they 
are still under general anaesthesia and kept fully sedated and ventilated for 
at least several hours to reduce the likelihood of damage to the 
anastomosed vessels through patient movement. Starting at admission to 
ICU, the flap and/or monitor flap are inspected hourly by trained personal. 
Additionally, the artery and vein of the pedicle are evaluated using a 
transcutaneous Doppler probe at the same time, even if there are no 
anomalous findings like paleness or swelling of the transplanted flap during 
inspection. These hourly examinations are continued for 72 hours, no matter 
whether the patient is still on ICU or has already been moved back to a 
general ENT ward. Afterwards the regime is loosened to some degree and 
the intervals for examinations are two hourly from then on for another 48 
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hours. So, a total of 120 hours is covered. After that time, the flap’s vitality 
is clinically assessed at least once daily (see Table 1).  
If only the smallest doubt relating to the perfusion situation arises, the 
patient is immediately taken back to the OR for reexploration and salvage 
operation, if necessary. 
 
2.4.2 Study Design 
The study was designed as a prospective clinical trial. Informed consent was 
acquired from the patients prior to inclusion. There was no randomization or 
blinding.   
2.4.3  Patient data of interest 
For all patients the following parameters were determined and written down 
in the study chart (also attached in the appendix):  
• Age 
• Weight 
• Heart rate 
• Blood pressure 
• Localization and type of cancer 
• Used flap for this procedure 
If continuous invasive monitoring of blood pressure and heart rate was 
available – as it always was in the OR and on ICUs – the data at the moment 
of injection of ICG were those of importance. If there was only intermittent 
non-invasive monitoring as provided on general wards the data was taken 
directly before and after the examination and then the mean value was 
Table 1:  Post-OP monitoring regime at LMU head and neck surgery department:  
Time after surgery 1–72 hrs. 3–5 ds 6–14 ds  2–4 wks 
clinical checks Hourly 2 hourly Once daily weekly 
Doppler examinations Hourly 2 hourly None  None 
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recorded. As there was no intention to measure an effect of the examination 
or injection of the dye in the blood pressure, no further analysis of 
circulatory data was performed. 
2.4.4  Time of examinations 
According to study protocol, all patients had to undergo three planned ICG 
angiography examinations. These had to take place at the following points: 
• 1st Examination: Intraoperatively (0h) following anastomosis 
 The first examination was always performed in the OR directly after 
anastomosis of the vessels, while the patients were still under general 
anaesthesia and continuously monitored. For these first examinations, 
the endoscope was mounted on a stand to reduce artificial 
movements. 
• 2nd Examination: 24h following surgery 
 At this point the patients were still on ICU and either sedated or fully 
awake, depending on their overall physical condition. There was 
continuous measurement of vital parameters in all the patients at this 
time. For these examinations, the endoscope was handheld. 
• 3rd Examination: 72h following surgery 
 The last examination was performed either on ICU or general ward. 
The endoscope was again handheld. 
2.4.5  Adaption of the schedule 
Changes to this regime were only made, if circumstances demanded it: 
• If the circulation seemed compromised in the OR following the original 
anastomosis, a second ICGA was performed after the probable cause 
of the problem was resolved. 
• In case of an assumed vascular compromise in the postoperative 
phase, the ICGA was performed immediately before salvage surgery, if 
both hardware and trained personnel was available at that time. 
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If in any of these cases a revision of the anastomosis was performed, the 
additional ICGA again marked a new start and was followed by a 72 hour-
postoperative monitoring period and 2 subsequent ICGAs.  
2.4.6  Requirements for the examined region 
The field of view during the examinations always included the following: 
• Transplanted flap 
• Surrounding, autochthonous tissue 
• ICG reference 
If the distance from the light source – in this case the tip of the endoscope – 
grows, the maximum excitation intensity and thus the returned fluorescence 
signal diminishes. Due to these optical and physical prerequisites, there 
were further demands on the placement of the investigating endoscope 
within the examined region (see Figure 2): 
• Ideally, the flap, the ICG reference and the surrounding tissue had to 
have the same distance from the endoscope 
• The endoscope had to be placed over the flap in a right angle 
 
Figure 2: Optimal position of the endoscope: perpendicular over the center of the flap. 
Maximum intensities of excitation light are reached at minimal distances from the 
endoscope in the center of the flap. In the peripheral field, the excitation intensity 
diminishes as the distance from the tip of the endoscope grows. 
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2.4.7  Execution of the ICG angiography 
First, the ICG solution was prepared for injection in the right concentration 
and dose. Second, the needed equipment consisting of the examination unit 
composed of endoscope, light source, camera with controller and video 
recording system was prepared. Also, additional instruments like spatula and 
sterile gauzes for revealing of the flap were put in place. 
Finally, the equipment was placed next to the patient so that the examiner 
had clear view of the screen while handling the endoscope and spatula and 
the assistant had uninhibited access to the venous catheter through which 
the ICG was to be administered. 
First, the field of surgery was cleaned of saliva and blood. Then, the region 
of interest (ROI) was shown in white light and the ICG reference was placed. 
After the flap region was clearly identified and pictures and a video sequence 
had been taken for reference, the view was switched to the fluorescence 
imaging mode and the light source was changed to red excitation light mode 
simultaneously. The video recording was then started and the ICG was 
administered intravenously, while the sequence was being recorded. The 
point of injection was marked by voice command on the video for later 
evaluation. On screen, the live uptake and maximum of fluorescence 
intensity within the flaps were viewed and compared to the surrounding 
tissue while being recorded. In the first examination (0h), the recording was 
longer than in the following because of better conditions, as a stand could be 
used and the patients were still under anaesthesia. In these longer 
examinations the beginning elimination of ICG could also be seen by falling 
fluorescence intensities, whereas the follow-ups were primarily intended to 
be as close to reality in later clinical use as possible and ended, when the 
maximum fluorescence was subjectively reached in flap and surrounding 
tissue.  
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2.5  Data acquisition 
2.5.1  Video and audio recording 
All examinations were recorded in the .mov-format by the AIDA system 
including the audio input via a headset. 
2.5.2  Data storage 
The acquired video data was first written on the internal hard drive of the 
AIDA system in real time. To ensure data protection, the data was copied to 
a CD or DVD and kept in a secure place, and the original data was wiped off 
the hard drive. 
2.5.3  Data processing 
For further interpretation of the acquired video sequences, Pulsion, the 
manufacturer of ICG, provided an appropriate evaluation software (IC Calc 
(Version 1.1, Pulsion Medical Systems, Munich, Germany)). It works by 
measuring the digitalized data from the video (RGB, values 0 – 255) over 
time as average values of user defined ROIs. The ICG reference was used as 
a calibration signal to normalize the acquired data according to changes in 
distance of endoscope and observed tissue. 
Since IC Calc can only process .avi-format files, the AIDA system’s .mov-
files had to be converted to the IC Calc-conform .avi-format. To do this, 
Adobe Premiere Pro (Adobe Systems Inc., San José, CA, USA) was used to 
read the fluorescence videos, cut them according to the audio recordings 
and convert them to an uncompressed .avi-format. 
Then the videos were imported into IC Calc. There again, regions of interest 
could be defined. In each sequence, three of these regions were determined: 
• ICG reference 
• Flap 
• Surrounding tissue 
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In the process of evaluation, special care was taken with regards to the 
selection of these regions of interest, since only oval or rectangular and no 
free shaped regions could be defined due to restrictions of the used 
software. To guarantee that the examination was interpreted correctly, these 
regions were placed in approximately the same distance from the centre of 
the video and thus the light source and close to each other to increase 
comparability. IC Calc then plotted the curves of fluorescence intensity for 
each region of interest into the same figure. The program allowed for saving 
of the plots embedded in a HTML-file as well of the raw data in a text file for 
later use and import in a better suited plotting program for publication 
purposes. 
For each sequence, both options for saving were used. 
2.5.4  Important values for examination 
The most important value that we aimed to derive from our measurements 
was the fluorescence index (FI), the quotient of gain in intensity of 
fluorescence in the flap versus the surrounding, autochtonous tissue. 
Another interesting value was the perfusion index (PI), the quotient of 
fluorescence slopes. 
Through IC Calc, however, only the following basic values could be 
determined directly: 
• Fluorescence intensity of ICG reference (Iicg) 
• Basal fluorescence intensity of the flap and surrounding tissue before 
injection of ICG (bIfl or bIst) 
• Time of onset of uptake (t0) 
• Maximum fluorescence intensity of the flap and surrounding tissue    
after injection (mIfl or mIst) 
• Time from injection to maximum fluorescence intensity in both flap 
and surrounding tissue (tfl or tst) 
All the fluorescence intensity data were provided as absolute values on a 
scale from 0, this means no light at all, to 100, which means maximum 
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intensity of fluorescence that can be registered by the camera and 
controller. IC Calc plotted the curves against time and the intensities had to 
be extracted by the examiner. 
2.6  Data evaluation 
2.6.1  Primary data 
The data from IC Calc were then read and directly transferred to a table in 
Microsoft Excel (Microsoft Corp., Redmont, WA, USA). This table contained 
the following information on all patients: 
• LMU study code for this patient 
• Date of examination 
• Time of examination after surgery 
• Age (in years) 
• Gender 
• Localization and type of cancer 
• Used flap 
• All values listed under point 2.5.4 as shown by IC Calc 
 (in s for time values and % for fluorescence intensities) 
 Time of injection on the video (ti in s) 
• Heart rate (HR in bpm = s-1) 
• Blood pressure (BP) systolic and diastolic (RRsys and RRdia in mmHg) 
• Type of venous access (peripheral or central) 
Time data was rounded to 0.5 seconds and fluorescence intensity was 
rounded to 0.5%. 
2.6.2  Secondary Data 
From the original data, some secondary data has been calculated and also 
entered into the same table. These were the calculations used: 
• Circulation time from injection (ti) until onset of uptake (TUO) 
  𝑇𝑈𝑂	 = 	𝑡0	– 	𝑡𝑖 
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• Time from onset of uptake to time of maximum FI in flap and 
surrounding tissue (TMF and TMS) 
  𝑇𝑀𝐹	 = 	𝛥𝑡-. 	= 	 𝑡-.	– 	𝑡0 
 𝑇𝑀𝑆		 = 	𝛥𝑡01 	= 	 𝑡01	– 	𝑡0 
• Increase in fluorescence intensity in both flap and autochthonous 
surrounding tissue (ΔIfl or ΔIst) 
  𝛥𝐼-. 	= 	𝑚𝐼-. 	− 	𝑏𝐼-. 
  𝛥𝐼01 	= 	𝑚𝐼01 	− 	𝑏𝐼01 
• Fluorescence Index (FI) is the quotient of maximum increase of FI in 
flap and surrounding tissue (FI) 
  𝐹𝐼	 = 	6789
67:;
	 
• Perfusion Index (PI)is the quotient of the mean slopes of uptake in the 
flap and the surrounding tissue (PI) 
  𝑃𝐼	 = 	𝐹𝐼	× >?@
>?A
= 	 6789	×	61:;
67:;		×6189
 
• Mean arterial pressure (MAP in mmHg) 
  𝑀𝐴𝑃 = 𝑅𝑅DEF +
H
I
(𝑅𝑅0K0 − 𝑅𝑅DEF) 
2.7  Randomization and blinding 
The study was neither randomized nor blinded since its purpose was merely 
to prove the feasibility of the method.  
2.8  Statistics 
In the preparation phase of the study, there were no considerations on 
statistics as far as case numbers were concerned, since its main purpose 
was to show, whether endoscopic ICG angiography is a useful, feasible and 
easy to perform method of determining surface perfusion of transplanted 
free flaps in the UADT and predict the state of the anastomosis. 
In the course of evaluating the study results, different statistical tests were 
applied. Because of the low case number, the evaluation was mainly of 
descriptive nature. The relatively small number of patients in the study led 
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to the use of the Mann-Whitney-U-Test to show the significance of the study 
results. For Correlations, Spearman’s test was used. 
All the secondary data was imported in SPSS (Version 17.0 for Windows, 
SPSS Inc., Chicago, IL USA) and then processed statistically. Graphics were 
created using either SPSS, Photoshop CS4 (Adobe Systems Inc., San José, 
CA, USA) or Powerpoint 2007 (Microsoft Corp., Redmont, WA, USA). 
2.9 Interpretation survey  
In order to assess the possible value of the real-time on-line interpretation 
of the examination in the OR, a video including 10 ICG-fluorescence 
sequences and the matching white light images was created using Adobe 
Premiere Pro CS 3 (Adobe Systems Inc., San José, CA, USA). The video 
included two sequences of patients who had to undergo revision surgery for 
arterial malperfusion und eight examinations of patent flaps with no 
abnormal findings for control.  
A total of 21 persons from the Department of Otorhinolaryngology and Head 
and Neck surgery at the University Hospital Munich participated in our 
interpretation study. This included 5 nurses and 16 medical staff members 
with experience ranging from students to attending head and neck surgeons. 
All personnel was familiar with postoperative flap monitoring techniques and 
from the medical staff, 11 of whom have seen ICG-examinations performed 
in the OR during the course of the study.  
All raters were shown the same 10 sequences with 8 patent and 2 
insufficiently perfused flaps each. This added up to a maximum of 210 
possible sequences to be assessed (168 patent, 42 insufficient), both for 
white light and ICGA sequences. The participants were asked to view the 
sequences only once and then give a statement on the actual perfusion 
situation. In writing, the participants then had to judge on the flap-perfusion 
on a 4-step-scale ranging from 1 (bad) to 4 (good) and need for operative 
revision first for the white light images and then second for the fluorescence 
videos.  
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2.10 Privacy policy 
All patient data were evaluated anonymously. The patients’ details were 
exchanged by alphanumeric codes (e.g. LMU XX) that had no relation to the 
names but indicated the sequence of surgeries and thus first examinations. 
In the table that included the results no names but only the codes were 
shown. All the consent forms had to show the full names and birthdays and 
were stored in a locked drawer, that only one person, Dr. med. Ch. Betz 
from the Department of ENT of the LMU University Hospital had access to. 
The other data, including tables, plots and the videos were completely 
anonymous and stored on either password or biometrically secured 
computer systems that only members of the research team could access. 
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3  Results 
3.1  Patient collective 
From December 6th 2007 to October 28th 2008, a total of 25 patients were 
included in the study according to the study protocol. Of those, five were 
female, 20 male. The patients were aged from 45 to 74 years (mean age 
60.5 years, Table 2).  
 
All patients suffered from cancer in the upper aero-digestive tract (UADT) 
and had to undergo reconstructive flap surgery following cancer resection 
either primarily or secondarily. While 92% (23/25) of the malignant 
formations were pathologically identified as squamous cell carcinoma, only 
8% (2/25) suffered from adenocarcinomas. The flaps used in the study were 
the free radial forearm flap (fRFF), free anterolateral thigh flap (fALT) and 
free fibula flap (fFF; see Table 3: Localizations and flaps used). 
 
All procedures were performed by one head and neck surgeon (Prof. Dr. 
med. U. Harréus) and there were no total or partial flap losses. 
Table 2: Distribution of sex and average age in years 
 Male Female Total 
Number 20 5 25 
Average Age (years)  58.53 68.54 60.52 
 
Table 3: Localizations and flaps used 
 Localization of defect  
Pharynx Tongue Root of 
tongue 
Floor of 
mouth 
Cheek Total 
Flap used fRFF 8 3 5 2 2 20 
 ALT 1 2 0 1 0 4 
 FF 0 0 0 1 0 1 
Total  9 5 5 4 2 25 
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3.2 Anastomosis Techniques 
All the arterial anastomoses were performed end-to-end in manual single 
suture technique with a monofilament 8-0 nylon suture and used either the 
A. thyreoidea, A. facialis or A. lingualis as donor vessels. For venous end-to-
end anastomoses venous mechanical anastomotic coupler devices (vMACD; 
GEM Microvascular Anastomosis Coupler, Synovis Companies Alliance Inc., 
Birmingham, AL, USA) with sizes between 2.5-4.0mm were used. Receiving 
vessels were either the V. jugularis externa or V. facialis. 
3.3 ICGA-Examinations 
3.3.1 Course of the examination 
The ICG angiography (ICGA) examinations could be performed on all 
patients at 0 hours in the OR. There were always two people needed to 
perform the angiography, since the examiner had to handle the endoscope 
and the attached camera and point it towards the region of interest as well 
as reveal the flap or improve view of it by using a spatula. An assistant had 
to inject the ICG solution.  
The ICGA was very well tolerated by sedated and awake patients alike, and 
there was no harm inflicted during the examinations. In the course of the 
study no adverse effects such as anaphylactic reaction or shock occurred 
following the administration of ICG. 
3.3.2 Duration of an examination 
The time to perform a complete ICG angiography was about 15 minutes, 
consisting of approximately 5 minutes to ready and assemble the endoscopic 
equipment and prepare the ICG dye for injection, another 5 minutes of 
actual examination and finally up to 5 minutes for disassembly of the 
instruments and storage of the data. 
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3.3.3 Problems encountered during examinations 
On one occasion, we encountered a technical difficulty with the foot pedal 
switch, which was used to start and stop recording of the video sequences 
and taking pictures. Apparently caused by a defective contact, it had to be 
repaired. During that time, the recording was managed by an assistant by 
using mouse and keyboard and the AIDA system’s graphic user interface. 
This way, the issue could be resolved without problems. 
A problem for recording and later off-line evaluation was excessive 
movement of an agitated or not fully oriented awake patient, when the level 
of sedation in the early postoperative phase on ICU was not deep enough 
anymore to still easily tolerate manipulation within the oral cavity. When 
sight of the ROIs was lost, it had to be found again in the ICG-enhanced 
view, since switching back to the white light mode could have missed the 
relevant phase of rising fluorescence. This was rather difficult in the early 
phases of each examination, because contrast of the basal fluorescence was 
very low and only rudimentary orientation was provided by the (always well 
visible) ICG reference. Rearranging the composition of ROIs was rather easy 
in the middle and late phases however, when contrast was higher and the 
good spacial resolution even revealed the stitching sutures for orientation. It 
was especially important to maintain the same distance from the flap, since 
this would have led to fluctuations in fluorescence intensities. 
Placement of the ICG reference in the awake patients was not always ideal, 
because the examination was mostly performed in a sitting or half-sitting 
position of the patient. When the localization of the flap was on the roof of 
the oral cavity, the reference had to be placed on the tongue, since it could 
not be attached to the pharynx. Also very deep localizations like the root of 
the tongue were problematic and the reference had then to be placed on the 
back wall of the oro-/hypopharynx.  In one case the platelet could not be 
placed due to postoperative swelling and the narrowness of the available 
space to perform the ICGA, as not even the entire flap could be revealed. 
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The flap could not always be completely revealed without risking damage to 
the tissue in very deep localizations like the root of the tongue. If that was 
the case, the flap was revealed as much as possible and then the ICGA was 
performed. 
The regime of three planned examinations for each patient could be followed 
for all but one patient (LMU 05), who had a very deep glossopharyngeal 
cancer resection and reconstruction and showed a massive postoperative 
swelling despite the routine steroid treatment. To not risk damage to the 
flap and its vessels, the team decided to avoid further manipulation to the 
site of surgery to reveal the flap. Therefore, the 2nd and 3rd examinations 
were waived in this patient. 
3.4 Cases 
Of the 25 patients, five had to undergo revision surgery based on clinical 
findings – including reduced arterial and/or venous Doppler probe signal, 
pale aspect on inspection or absence of bleeding after pinprick testing. One 
of them had to be revised twice because of suspected impending flap failure. 
The remaining 20 patients showed completely uneventful postoperative 
courses and normal healing and did specifically not require surgical re-
evaluation of the perfusion situation. 
3.4.1 Patients with immediate early revision following Anastomosis 
Two patients had to be revised due to suspicious clinical findings in the OR 
following anastomosis directly after the neck had been closed. 
The first patient, LMU 06, aged 66, has had a T3 primary cancer of the soft 
palate including the right tonsil. The procedure included resection of the 
cancerous lesion and neck dissection. After the radial forearm flap had been 
elevated, the flap was first sewn in place and then the pedicle artery was 
connected to the superior thyroid artery with single interrupted sutures and 
the vein was anastomosed to the external jugular vein using a venous 
mechanical anastomotic coupler device (vMACD, see 3.2). Intraoperatively, 
an excellent flow in the anastomosed vessels and good vitality of the flap 
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were verified. An additional monitor flap was sewn in the side of the neck 
and then the flap was sewn into the tonsil’s loge. When the flap’s vitality was 
checked one last time in the OR before transferring the patient to the ICU, 
the flap appeared pale and there was almost no bleeding after pinprick 
testing. Upon these findings it was decided to perform immediate revision 
surgery. While the preparations for a reopening of the neck took place, the 
ICGA was performed for a first time in this patient. In stark contrast to 
previous ICG examinations, there was subjectively barely any uptake of 
fluorescence in the flap, while fluorescence was present in the 
autochthonous tissue and showed the expected behaviour. The intra-
operative assessment showed a lack of blood flow in the artery due to a 
kinking of the pedicle. After this problem had been resolved by shortening 
the pedicle and renewing the arterial anastomosis, the neck was closed 
again. Subsequently, the flap appeared rosy and showed appropriate 
bleeding upon pinprick testing and a second ICGA was performed (see Figure 
3). In this examination, the flap also took up fluorescence as expected. After 
this intervention, the further postoperative course of LMU 06 was 
uneventful. 
The later off-line ICGA analysis showed low FI of 0.33 and PI of 0.29 prior to 
revision which both rose after re-establishing perfusion to a FI of 0.93 and a 
PI of 0.68, respectively. 
In a second case, on LMU 23, a 64 years old male patient, who also suffered 
from T3 oropharyngeal cancer including the right tonsil and the root of the 
tongue, a secondary reconstruction was performed one week after resection 
of the cancer, using a free radial forearm flap (fRFF). Again, the pedicle 
artery was anastomosed with the superior thyroid artery using button 
sutures, whereas a vMACD was used to connect the pedicle vein to the 
external jugular vein. At the end of surgery both, flap and monitor flap, 
appeared “unusually pale”. The ICGA showed delayed and greatly reduced 
fluorescence of the flap compared to the surrounding tissue. 
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Figure 3: Images of Patient LMU 06 before (1 & 2) and after (3 & 4) revision in 
white light and ICG angiography mode.  
The flap appears pale (1) and takes up less fluorescence than the surrounding tissue (2). In 
the pre-revision ICGA only a low increase in fluorescence intensity in the flap could be found 
corresponding with a low FI of 0.33 and PI of 0.29 (5). After re-exploration, the flap is of 
rosy colour and bleeds following pinprick testing (3) and shows stronger fluorescence then 
before (4). The postoperative ICGA shows better ICG uptake and fluorescence in the flap 
translating into a FI of 0.93 and a PI of 0.68 (6). 
 
Due to the clinical findings it was decided to immediately revise the flap. 
Upon exploration, missing arterial blood flow was found. Although the 
definitive cause for this remained unclear, resection of the arterial 
anastomosis and renewed anastomosis to the more proximal stem of the 
superior thyroid artery succeeded in restoring flow in the pedicle artery. 
Intraoperative Doppler examination showed also good flow of the venous 
branch and so the neck was closed again. The flap now appeared well 
perfused and presented itself with healthy colour and active bleeding after 
5 
si
6 
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pinpricking. In the ICGA now better uptake of the dye could be seen (see 
Figure 4). In the postoperative phase, the patient had to undergo another 
revision due to a clinically pale aspect of the flap (see 3.4.3 for details). 
When the ICGA sequences were further analysed, the FI before revision was 
0.37 with a PI of 0.20. The ICGA analysis after renewing the anastomosis 
clearly improved to values of 0.73 for FI and 0.67 for PI. 
  
  
  
Figure 4: LMU 23 before and after revision:  
again, pale aspect of the flap (1) combined with reduced ICG-uptake in the flap (2). The 
ICGA shows reduced uptake of ICG in the flap with a FI of 0.37 and PI of 0.20 before 
revision (5). After renewing the anastomosis, the flap appears more rosy (3) and the 
maximum ICG fluorescence increases (4). The ICGA confirms the clinically improved 
perfusion situation with values of 0.73 for FI and 0.67 for PI (6). 
 
 
5 6 
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3.4.2 Revised Patients without pathologic intraoperative findings 
Two patients, namely LMU 23 and LMU 25, underwent revision surgery, that 
showed no pathologic findings concerning perfusion intraoperatively. 
LMU 23, who had also been previously revised when still in the OR from the 
original surgery, again showed a rather pale flap in clinical examination 
exactly 24 hours following anastomosis. Indication for the surgery was based 
on the clinical findings, because even the hint of vascular compromise 
should result in operative reassessment. While preparations for the re-
exploration were underway, a preoperative ICGA was performed, which 
turned out with relatively fast and good uptake of fluorescence within the 
flap and thus stood in contrast to the clinical findings. Intraoperatively 
though, there were no pathologic findings, that could have accounted for the 
paleness of the flap. Because there was no true anastomotic revision, this 
ICGA was considered a regular 2nd examination 24 hours following 
anastomosis and there were neither an extended follow-up period nor 
additional ICG-angiographies afterwards. The flap healed in uneventful 
afterwards (see Figure 5). 
  
 
 
Figure 5: WL (1) and ICG imaging (2) of LMU 23 directly before revision: 
The flap can hardly be completely revealed, the tongue being pushed away by a wooden 
spatula. It appeared rather pale on one of the hourly clinical checks, in the WL footage it 
seems quite well perfused, though. In the ICGA there is adequate fluorescence increase 
(Note: images taken from IC Calc hence the ROIs for evaluation). The pre-revision ICGA 
indicated good perfusion of the flap with a FI of 0.79 and a PI of 0.69 (3). 
3 
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LMU 25, a 54 years old, 130kg obese patient with a T4 oropharyngeal cancer 
receiving a fRFF showed signs of vascular compromise 14 hours after 
anastomosis. The flap appeared pale, although adequate bleeding after 
pinpricking was present. A Doppler-probe examination was hardly possible 
due to the patients weight and extensive postoperative swelling of the neck 
combined with extended cutaneous emphysema surrounding and originating 
from the tracheostomy. The vessels could not be doubtlessly identified 
acoustically and no information on either arterial or venous flow could be 
obtained. Because of the possible compromise of the flap, immediate 
operative assessment of the anastomoses was indicated, although clinical 
signs were equivocal. The preoperative ICGA showed good and rapid uptake 
of ICG and good fluorescence intensities in the flap (see Figure 6). In the OR, 
there were no pathologic findings to the flap or pedicle and the neck was 
carefully closed again without intervention. Again, since there was no 
operative revision of the anastomosis, this was considered a regular 2nd 
examination and the schedule was adapted accordingly. The further 
postoperative course was uneventful. 
  
 
 
Figure 6: LMU 25 14 hours after anastomosis: 
Pale aspect of the flap with arterial bleeding after pricking (1). Good and fast uptake and 
almost equal intensities of fluorescence in flap and surrounding tissue in the ICGA (2). 
Analysis later showed a good pre-revision perfusion with a FI of 0.93 and a PI of 0.50 (3). 
 
3 
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3.4.3 Patients with revisions without preoperative ICGAs 
Two patients showed clinical signs of vascular compromise, but could not be 
preoperatively examined by an ICGA. In this case postoperative ICGAs were 
performed and considered 1st examinations with 2 further ICGAs following, 
since there was an operative revision of the anastomosis. 
The first patient, LMU 13, aged 45 years and male, had a T4 relapse of a 
carcinoma of the floor of the mouth with infiltration of the mandible. Due to 
the extent of the disease, partial resection of the mandible and 
reconstruction using a osteo-cutaneous fibula-flap was necessary. 11 hours 
after anastomosis, the neck and region around the floor of the mouth 
appeared swollen and the flap unusually pale. Since this was judged as an 
apparent sign of an acute vascular compromise, the situation called for 
emergency salvage surgery and it was decided there was no time to perform 
a preoperative ICGA. Intraoperative investigations showed a good flow 
within the pedicle vessels with accordingly assumed good perfusion of the 
bone transplant, but an impaired perfusion of the skin flap. After the skin 
flap had been released of some tension by undoing some of the sutures, it 
was immediately reperfused and sewn in again without tension. The 
postoperative clinical assessment showed a healthily coloured flap and the 
ICGA turned out with normal findings (see Figure 7). In the further 
postoperative course, a wound dehiscence resulted in the formation of a oro-
cutaneous fistula that had to be operatively revised twice. Also, 
intraoperatively taken smears showed colonization with MRSA. 
The second patient, LMU 19, a 60 years old male patient with T4 
oropharyngeal carcinoma treated with a free radial forearm flap transplant, 
showed a livid and swollen monitor flap 22 hours after anastomosis. Due to 
suspicion of venous congestion, an emergency salvage surgery was 
scheduled. A preoperative ICGA could not be performed. Upon reopening the 
neck, complete kinking of the pedicle with venous congestion due to 
thrombosis was found. Resection and renewing of the venous anastomosis 
allowed for stable venous outflow and lead to rapid improvement of the 
clinical aspect. In the postoperatively performed ICGA, the findings were 
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unsuspicious of any problems (see Figure 8). The further postoperative course 
was uneventful. 
  
 
 
Figure 7: LMU 13 with reconstructed floor of the mouth:  
Postoperative assessment showed clinically rosy flap (1), after tension on it had been 
released. The ICGA showed normal and arguably subjectively reduced fluorescence of the 
flap (2), which could not be confirmed, when analyzed later. The FI was 0.80 and the PI 
0.72 (3). 
 
  
 
 
Figure 8: LMU 19, assessment after revision 22 hours following original 
anastomosis: 
Very good perfusion situation of the flap clinically (1) and in the ICGA (2). The later 
evaluation showed good perfusion with an FI of 0.89 and PI of 0.39 (3). 
 
3 
3 
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3.5 Evaluation 
3.5.1 On-screen interpretation of the videos 
While the videos of the fluorescence angiography were recorded, the 
monitors were closely watched for apparent differences in flap perfusion. The 
examiners and the surgeon judged the situation based on their subjective 
impression. In the OR, two patients (LMU 06 and 23) subjectively showed 
lower fluorescence intensities in the flaps. When those were assessed 
intraoperatively during revision, loss of arterial blood flow was found. The 
arterial anastomoses had been renewed subsequently in both cases, and a 
normal blood flow and clinical findings returned afterwards. 
When clinical assessment according to the standard post-op monitoring 
schedule for free-flap transplants lead to a surgical revision and no 
pathologic findings were obtained intraoperatively in two cases (LMU 23 and 
25), also the additionally performed ICGA before revision surgery was 
subjectively normal with rapid and homogenous uptake in both flap and 
surrounding tissue. 
In two cases (LMU 13 and 19), preoperative ICGAs could unfortunately not 
be performed, despite pathologic clinical findings (paleness of the flap in 
one, livid monitor flap in the other case), because the surgeries were 
considered to be highly urgent emergency salvage procedures and a delay 
through the ICGA was not desired. After the problems had been surgically 
resolved and the clinical findings were in the normal range again, the now 
obtained ICG footage also showed normal results. 
In all other cases, a total of 58 examinations were performed, which all were 
subjectively unsuspicious. 19 patients had all 3 examinations (total of 57 
ICGAs) while one patient only had a single ICGA before swelling impeded the 
subsequent examinations. There were also no extraordinary clinical findings 
at the times of those examinations. 
Mere real time viewing of the ICG uptake showed, that in all patients the 
same sequence of fluorescence phases could be found. After an initial phase 
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of missing fluorescence following injection of the dye raising intensity was 
noticeable first in the surrounding tissue, then in the flap, before both areas 
reached their maximum levels of fluorescence intensity (see Figure 9).	
 
 
 
Figure 9: Typical sequence of raising ICG fluorescence (LMU19 0h):  
Endoscopic image of the operational field in white light mode (1) showing flap and ICG 
reference with surrounding tissue. ICG fluorescence imaging of the same area before 
injection of ICG (2), during the arterial enrichment phase (3) and after maximum intensity 
is reached also in the flap (4). 
 
 
3.5.2 After-Processing of Video Material 
Each of the sequences taken during the ICGA was cut afterwards and 
transferred from .mov-format into the .avi-format. The videos were either 
used in their original form or cut so that the moment of injection, which had 
originally been marked on the recording acoustically, became the first frame 
of the re-cut clip. 
Depending on the used PC hardware this procedure took about 5-10 
minutes. There was no data loss during the transformation process. 
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3.5.3 Interpretation using IC Calc and extracting data 
After the respective regions of interest had been identified and marked on 
the first frame, the .avi-files were fed into Pulsion’s IC Calc program and  
processed to be put out as a two-dimensional graph showing the slopes of 
the fluorescence intensities of the ROIs in their respective colour, which had 
been previously assigned (see Figure 10). 
Also, the slope is calculated by IC Calc based on a routine not further 
specified by Pulsion.  
 
 
Figure 10: Typical IC Calc output file (LMU 19 0h):  
Slopes of ICG reference (yellow), flap (red) and surrounding tissue (green) from injection 
(0s) until end of video recording (approximately 69s). Note the synchronous begin of raising 
fluorescence intensities at approximately 33s and that the surrounding tissue reaches 
maximum intensity earlier (approx. 56s) when compared to the flap (approx. 80s). Also 
included are the slopes which IC Calc determines. 
The IC Calc plot depicts the aforementioned sequence of more rapid onset of fluorescence in 
the autochtonous tissue (green) compared to the flap (red) graphically, which can be 
regularly seen in each patient (also see 3.5.1 and Figure 9)  
 
The acquired data - e.g. intensities at basal and maximum levels - was then 
transferred into a Microsoft Excel file. From the raw data, Excel calculated 
the derived data according to the formulas given in 2.6.2. Additionally, the 
Excel file was transformed into a SPSS sheet to allow more detailed analysis. 
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Sometimes the ICG reference’s fluorescence intensity alternates, while the 
observed ROIs` intensities do not and vice versa (see Figure 11). In this 
particular case the fluctuation was caused by the thread attached to the 
reference, which involuntarily moved against the reference’s predefined ROI. 
Other causes of ragged curves were movement of the endoscope against the 
flap and affected all ROIs (see Figure 12). Since the program could not 
eliminate these fluctuations, whatever the cause, automatically if they 
occurred, the examiner had to choose consistent values. Watching the 
sequence play along while the curves evolved, this was an easy task.  
 
Figure 11: Fluctuating fluorescence intensity of the ICG reference with unaffected 
flap ROIs (LMU 22 0h). 
 
 
Figure 12: Extreme movement in an awake patient (LMU 20 72h) affecting both, 
the ICG reference as well as the flap ROIs. 
 
In the first patient to be included into the study all three examinations were 
performed. Due to lack of experience with the method of analysis and its 
requirements – especially possibly still image –  a later objective evaluation 
of the videos was not possible because of permanent movement of the 
endoscope and change of distance to the flap. In all the later patients great 
care was taken to improve conditions and minimize movement.  
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This fact reduces the count of patients statistically evaluated to 24, of whom 
one only got a first examination due to postoperative swelling that 
prevented an exposition of the flap (LMU 05). 
3.6 Calculations 
3.6.1 Number of evaluated Examinations 
The examinations were primarily classified as first, second or third exam 
according to study protocol.  
In case of revision the respective examinations were re-classified as 
“revision needed” if pathologic findings were identified intraoperatively or 
“no revision needed” if it turned out that there were no pathologic findings.  
In that case, “no revision needed” replaced the examination due at that time 
(e.g. 1st exam – “no revision needed” – 3rd exam). If a revision turned out to 
be “needed”, it was treated as a first exam with another two ICGAs to 
complete the cycle (e.g. 1st exam – “revision needed” – 2nd exam – 3rd 
exam). 
Had a pre-revision examination not been possible, the following post-op 
check-up was classified as “only post-revision” and considered as a second 
with one last following ICGA (e.g. 1st exam – “only post-revision” – 3rd 
exam, see Table 4). 
Table 4: Count of Examinations 
 
Examinations n= 
1st Exam 25 
2nd Exam 23 
3rd Exam 24 
Revision needed 2 
No revision needed 
Only post-revision  
Total 
2 
2 
78 
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3.6.2 Cardiac Parameters 
Cardiac parameters were noted for the majority of the patients. Mean 
arterial pressure (MAP) and heart rate (HR) increased with growing timely 
distance from surgery in most patients (see Table 5 and Table 6). 
Table 5: Statistics of mean arterial pressure (MAP) [mmHg]. 
 
Examinations 1st Exam 
(n=24) 
2nd Exam 
(n=19) 
3rd Exam 
(n=20) 
Mean 79,04 88,30 94,55 
95% conf. interval 74,1 - 84,0 81,8 - 94,8 89,3 - 99,8 
Std. deviation 11,37 13,87 11,23 
Minimum 58 69 70 
Maximum 
Range  
108 
50 
116 
47 
115 
45 
 
Table 6: Statistics of heart rate (HR) [bpm]. 
 
Examinations 1st Exam 
(n=23) 
2nd Exam 
(n=19) 
3rd Exam 
(n=20) 
Mean 57,17 82,84 85,45 
95% conf. interval 52,8 - 61,6 76,8 - 88,9 80,4 - 90,5 
Std. deviation 10,15 12,50 10,77 
Minimum 43 57 64 
Maximum 
Range  
85 
42 
104 
47 
100 
36 
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Figure 13: Plot of HR and MAP against each other: 
Revised flaps do not behave differently than the uneventful flaps. Regression line added 
(red).  
 
MAP and HR show a significant correlation of 0.568 (Spearman's Correlation; 
p < 0.01). Subgroups seem to form clouds around a regression line, with 
narcotized patients tending to have lower heart rate compared to the later 
measurements, which is most probably due to anaesthesia (see Figure 13). 
In those patients who had to be revised, the HR (mean 67/min, range 58 - 
76/min) and the MAP (mean 74,8 mmHg, range 69,7 - 80,0 mmHg) do not 
significantly differ from the measured values during regular first 
examinations (p=0.55 Mann-Whitney-U-Test). 
3.6.3 Time intervals 
Time from injection until onset of fluorescence (TUO; time until onset of 
fluorescence increase) ranged from 5 to 38 seconds and was identical for 
flap and surrounding tissue. After first signs of uptake of the dye, maximal 
fluorescence was reached earlier in the original tissue then in the 
transplanted (4 - 35s vs. 5 - 54s; see  Table 7 ) in all patients. 
The first value of interest was the time from injection until onset of 
fluorescence increase (TUO). The intervals were longest in the first 
examinations and became shorter with elapsing time from surgery. There is 
no obvious explanation, why TUO was shortest in the 2nd exam (see Table 8). 
 
3 Results 
42 
 
Table 7: Fluorescence build-up times: 
 
Examinations n= Range Mean Std. 
TUO 73 5 - 38 12,78 5,95 
TMS 
TMF 
73 
73 
4 - 35 
5 - 54 
12,21 
17,44 
6,13 
10,49 
 
In flaps which needed revision in the OR directly after anastomosis the TUO 
did not differ significantly from regular first examinations (n=2, mean 
15.50s, range 13 - 18s; p=1.0 Mann-Whitney-U-Test). 
Table 8: Time intervals until onset of raising fluorescence intensities (TUO): 
 
Examinations 1st Exam 
(n=23) 
2nd Exam 
(n=21) 
3rd Exam 
(n=23) 
Mean 16.68 10.14 12.0 
95% conf. interval 13.3 - 20.0 8.2 - 12.0 10.2 - 13.8 
Std. deviation 7.51 4.27 4.17 
Minimum 5 5 6 
Maximum 
Range  
38 
33 
21 
16 
20 
14 
 
Also of interest were fluorescence build-up times (see Table 7). This means 
the times until the maximum fluorescence intensities were reached in the 
flap (TMF; time until maximum fluorescence in the flap) or the surrounding 
tissue respectively (TMS; time until maximum fluorescence in the 
surrounding tissue). 
In the original surrounding tissue, the TMS (time until maximum 
fluorescence in the surrounding) is longer directly after anastomosis than 
after 24 or 72 hours (see Table 9). The same applies for the TMF (time until 
maximum fluorescence in the flap) (see Table 9 10). In all fluorescence 
examinations the maximum intensity was reached earlier in the surrounding 
tissue than in the transplanted flap. Shortly after surgery the mean time 
difference was 9.96 seconds and was reduced to 4.58 seconds after 24 
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hours and was negligibly low with a mere 0.73 seconds 72 hours 
postoperatively.  
Table 9: Time intervals until maximum fluorescence in the surrounding (TMS): 
 
 
Examinations 1st Exam 
(n=23) 
2nd Exam 
(n=21) 
3rd Exam 
(n=23) 
Mean 16.39 8.90 11.57 
95% conf. interval 13.0- 19.8 8.0 - 9.9 9.5 - 13.7 
Std. deviation 7.96 2.01 4.87 
Minimum 7 5 4 
Maximum 
Range  
35 
28 
15 
10 
27 
23 
 
Table 10: Time intervals until maximum fluorescence in the flap (TMF): 
 
Examinations 1st Exam 
(n=23) 
2nd Exam 
(n=21) 
3rd Exam 
(n=23) 
Mean 26.35 13.48 12.30 
95% conf. interval 20.7 - 23.0 10.6 - 16.4 10.5 - 14.1 
Std. deviation 12.96 6.37 4.28 
Minimum 8 5 5 
Maximum 
Range  
54 
46 
33 
28 
24 
19 
 
3.6.4 Correlation between cardiac parameters and TUO, TMS and TMF 
It was found that there is a low negative correlation between the 
cardiovascular factors (heart rate and blood pressure) and the time needed 
to register first signs of fluorescence and that it is stronger for heart rate 
than it is for blood pressure (HR -0.35; MAP -0.18; n=61). Also, circulatory 
factors were shown to have an even stronger influence on flap perfusion (HR 
-0.54; MAP -0.37; n=61) than on the original tissue (HR -0.37; MAP -0.22; 
n=61), since faster paced patients reached maximal flap fluorescence earlier 
than slower paced ones (see Table 11). 
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Table 11: Spearman's correlation between circulatory factors and fluorescence 
build-up: 
 
Spearman's rho TUO TMS TMF 
HR Correlation coefficient -0.348 -0.372 -0.537 
n= 61 61 61 
MAP Correlation coefficient -0.178 -0.217 -0.372 
n= 61 61 61 
 
The revised flaps do not show different behaviour than the uneventful flaps 
(see Figure 14). 
  
Figure 14: Plots of HR vs. time until maximum fluorescence is reached in both surround 
tissue (TMS; left) and flap tissue (TMF; right) for all three examinations (color coded, see 
legend). The cases when revision was necessary are displayed with red pentagons and do 
not differ from the other examinations in regard to the distribution.  
 
3.6.5 Fluorescence Index (FI) 
Fluorescence Index (FI), the ratio of maximum fluorescence intensity 
between flap and surrounding tissue, was calculated for all examinations 
except those of the first patient according to the formula provided in 2.6.2 
(see Table 12). 
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In those examinations, which were not associated with a surgical re-
evaluation or revision, a mean value of 0.85 was reached (n=71), with 
values ranging from 0.60 to 1.00. Most patients showed a continuously 
raising FI with growing time from initial surgery following the overall trend, 
although some showed falling FIs without obvious reason or postoperative 
complications. The mean FIs rose from 0.819 directly after anastomosis to 
0.859 after 24 hours respectively to 0.883 after 72 hours (see Figure 15 and 
Figure 16). 
In those cases, that had a truly compromised arterial flow (n=2), the FI was 
0.33 or 0.37, respectively. After revision, these values returned to the 
normal range immediately, namely 0.73, respectively 0.93. Those cases, 
which underwent revision surgery lacking any true perfusion issues, the FIs 
were also in the normal range (0.79-0.93; mean 0.85; n=4) and mixed well 
with the regular measurements.  
The revised flaps` FIs differed significantly from the other cases’  first 
regular examination (p<0.01, Mann-Whitney-U-test). 
Table 12: Fluorescence index (FI) with descriptives for all subgroups: 
Examinations n= Mean 95% 
Conf. Int. 
Std. Dev. Range 
1st Exam 23 0.819 0.77-0.86 0.105 0.60-0.96 
2nd Exam  
3rd Exam 
21 
23 
0.859 
0.883 
0.82-0.90 
0.84-0.92 
0.081 
0.096 
0.69-0.96 
0.68-1.00 
Revision needed  2 0.351 0.12-0.57 0.025 0.33-0.37 
No revision needed 2 0.860 0.00-1.73 0.097 0.79-0.93 
Only post-op 2 0.847 0.25-1.45 0.067 0.80-0.89 
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Figure 15: FI shown in regular exams as combined scatter and box plots 
(n=23 for 1st and 3rd exam, n=21 for 2nd exam) and in revised flaps depicted 
as dots due to low numbers (n=2 for necessary revisions, n=2 each for non-
arterial problems). 
 
 
 
Figure 16: Increasing ratio of fluorescence intensity with growing time from surgery within the 
observation period. Intrapatient development shown by dotted black line. 
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If a cut-off value of 0.50 for the FI was drawn, only the flaps with a true, 
acute vascular compromise are found below this threshold whereas all other 
measurements lie above. 
3.6.6 Perfusion Index (PI) 
Perfusion index (PI; ratio between slopes of the curves of fluorescence gain 
in the flap and surrounding) was determined by calculating the mean slopes 
from the raw data and not using IC Calc’s build-in feature since in some 
cases it could not be used due to movement artifacts in awake patients. The 
formula used was 𝑃𝐼 = 	∆𝐼𝑓	×	∆𝑡𝑠∆𝐼𝑠	×	∆𝑡𝑓. In this formula ∆I stands for gain in 
fluorescence intensity, ∆t for time until maximum intensity, indices f and s 
for flap or surrounding, respectively. 
PI ranged from 0.21 to 2.00 (mean 0.67; median 0.68). In patent flaps, PI 
was 0.21 - 2.00 and in the two insufficient flaps 0.20 or 0.29. Like the FI, PI 
improved with time from anastomosis (see Table 13).  
The PI for flaps which needed revision were 0.20 and 0.29, which were low 
values, when compared to the other examinations, but were still within the 
normal range in contrast to the FI. 13 percent (3/23) of the PIs measured at 
0 hours after anastomosis and 4.8 percent (1/21) at 24 hours 
postoperatively also showed a value below 0.30. All 72 hour PIs were above 
0.30 (see Figure 17 and  Figure 18). 
Table 13: Perfusion index (PI) with descriptives for all subgroups: 
Examinations n= Mean 95% 
Conf. Int. 
Std. Dev. Range 
1st Exam 23 0.570 0.47-0.67 0.234 0.21-1.06 
2nd Exam  
3rd Exam 
21 
23 
0.635 
0.853 
0.55-0.73 
0.71-0.99 
0.192 
0.327 
0.27-0.91 
0.51-2.00 
Revision needed  2 0.243 -0.37-0.86 0.068 0.20-0.29 
No revision needed 2 0.598 -0.61-1.80 0.134 0.50-0.69 
Only post-op 2 0.515 -2.09-3.12 0.290 0.31-0.72 
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Figure 17: Combined scatter plot and box plot of PI for all subgroups. Flaps with acute 
vascular compromise range below a threshold of 0.30 and are depicted with dots due to 
low case numbers (n=2). 
 
 
 
Figure 18: Intrapatient development of PI over time. 
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PI values for flaps suffering from vascular compromise differed significantly 
from the values taken from regular first examinations (p<0.05, Mann-
Whitney-U-test). 
3.6.7 Reproducibility of FI and PI 
In order to check the reproducibility of each FI and PI, one fluorescence 
sequence of a well perfused flap was repeatedly analysed 14 times with 
different randomly assigned pairs of ROI for the flap and the surrounding 
tissue. Only a relatively minor scatter was found for the FIs with values 
ranging from 0.75 to 0.93 (mean 0.83, median 0.83; std. dev. 0.07). Even 
the lowest value of 0.75 stayed well above the assumed threshold for 
vascular compromise of 0.50. 
At the same time, PI ranged from 0.34 to 0.86 (mean 0.52; median 0.44; 
std. dev. 0.44) and thus scattered a lot more (see Figure 19). 
 
 
3.6.8  Correlation between FI and PI 
A moderate significant correlation between FI and PI was found for all 
patients. Due to small numbers, a subgroup analysis was not possible 
(Spearman's rho; 0.437). 
 
 
Figure 19: Left: Endoscopic ICG-image showing some of the ROI pairs (left). 
Corresponding pairs are depicted the same color. ROIs were randomly selected and false 
colors in this CGI added during afterprocessing (no original data). 
Right: Values of the different measurements for FI (black) und PI (white) with median lines 
(massive line for FI, dotted line for PI). (n=14)  
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3.6.9  Summarized comparison of FI and PI 
In summary, when FI and PI are compared, there is a definitive threshold of 
0.50 for the FI below which no patent flap was found. In contrast, below a 
threshold of 0.30 for the PI, there were still 5.9 percent (4/67) of patent 
flaps which were also below this threshold. As well, the Mann-Whitney-U test 
suggests a better separation of values for insufficient and uneventful flaps 
when using the FI (p < 0.01) as in comparison to the PI (p < 0.05). 
3.7 Possible value of real-time on-line interpretation 
3.7.1 Interpretation of perfusion situation 
As described in Materials & Methods, 21 raters were shown a total of 210 
sequences and then asked for their judgement. From the 168 patent flaps 
shown, 167 (99.4%) were evaluated regarding the clinical perfusion status 
by the participants (in one form the according box was not checked by the 
participant). All 168 (100%) ICG sequences were judged. 127 (76,1%) were 
considered to have sufficient (“adequate” and “good”) perfusion in the white 
light images as opposed to 148 (88,1%) in the ICG angiography. Also, 6 
(3,6%) of the patent flaps were judged to suffer from insufficient (“bad” and 
“poor”) perfusion from clinical aspect whereas there were none in this 
category in ICG view. 
All 42 sequences of the malperfused flaps were evaluated by the participants 
for both white light (100%) and ICGA (100%). From the 42 insufficiently 
perfused flaps, that had to undergo revision surgery, only 28 (66,7%) were 
assumed to have insufficient (“poor” or “bad”) perfusion from the clinical 
impression alone, while the ICG angiography lead to a correct identification 
in 38 cases (90,5%). In neither white light nor ICG imaging were any 
compromised flaps considered to have “good” blood supply (see Table 14 and 
Figure 20).  
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 Figure 20: Judgment on flap perfusion situation in four steps from 1 (bad) to 4 (good) for 
patent and insufficient flaps, based on both, white light and ICG imaging. 
 
Regarding the judgment of perfusion situation, the mere white light 
interpretation has a sensitivity of 76.0% and a specificity of 66.7%, when 
grouping “good” and “adequate” as sufficient perfusion against “poor” and 
“bad” as insufficient perfusion. ICG angiography has a sensitivity of 88.1% 
and a specificity of 90.5%. 
  
When applying a scoring system reaching from 1 for “bad” up to 4 for “good” 
there are differences in the mean scores between sufficiently and 
Table 14: Judgment on flap perfusion situation in four steps from 1 (bad) to 4 (good) for 
patent and insufficient flaps, based on both, white light (WL) and ICG imaging.  
 Patent Flap 
WL 
Patent Flap 
ICG 
Insuff. Flap 
WL 
Insuff Flap 
ICG 
Bad 6 (3.6%) 0 (0%) 6 (14.3%) 21 (50.0%) 
Poor 34 (20.4%) 20 (11.9%) 22 (52.4%) 17 (40.5%) 
Adequate 87 (52.0%) 58 (34.5%) 14 (33.3%) 4 (9.5%) 
Good 40 (24.0%) 90 (53.6%) 0 (0%) 0 (0%) 
Total 167 (100%) 168 (100%) 42 (100%) 42 (100%) 
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insufficiently perfused flaps depending on whether they were seen under 
white light or in ICG-fluorescence (see Table 15). 
Table 15: Applying the scoring system to the judgments leads to the mean perfusion 
scores (1 point for “bad”, 2 points for “poor” and so on). The point values per category 
(e.g. “good”) were multiplied by how often they were given (n) for patent and insufficient 
flaps both under white light and ICG conditions.      
 
 Patent Flap 
WL 
Patent Flap 
ICG 
Insuff. Flap 
WL 
Insuff Flap 
ICG 
Bad x 1 n6 x 1 = 6 n0 x 1 = 0 n6 x 1 = 6 n21 x 1 = 21 
Poor x 2 n34 x 2 = 68 n20 x 2 = 40 n22 x 2 = 44 N 17 x 2 = 34 
Adequate x 3 n87 x 3 = 261 n58 x 3 = 174 n14 x 3 = 42 n4 x 3 =12 
Good x 4 n40 x 4 = 160 n90 x 4 = 360 n0 x 4 = 0  n0 x 4 = 0  
Total Score 495 574 92 67 
Total n 167 168 42 42 
Formula 495 / 167 574 / 168 92 / 42 67 / 42 
Mean Score 2.96 3.42 2.20 1.60 
 
In white light, the average score for patent flaps was 2.96 and for 
insufficient flaps it was 2.20. Accordingly, using ICG angiography, patent 
flaps had a higher score of 3.42 and insufficient flaps had a lower score of 
1.60.  
3.7.2 Interpretation of need of revision 
Of the 210 sequences shown, 21 raters gave their opinion on need for 
intervention for 167 of the WL sequences (79.5%) and 199 of the ICG 
sequences (94.8%).  
In WL, 47.1% (16/34) could be correctly identified and 12.0% (16/133) 
were wrongly indicated for revision. In contrast, ICG helped identify 74.4% 
(32/43) of insufficient flaps and only 4.5% (7/149) of patent flaps were 
assumed to be compromised. 
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4 Discussion 
4.1 Usage of free flap transfer 
Free flap transfer has become a standard procedure for aesthetic and 
functional treatment of soft tissue defects. A wide range of different flaps is 
available depending on size, localization and tissue type of the defect(17, 18, 
20, 21, 45-49).  
Disa(50) and Lutz(51) both suggest a simplifying approach to donor site 
selection, that shall lead to lower complication rates and reliable surgical 
results as the surgeons familiarize themselves more with the used flaps. In 
Disa's 13 years spanning study (1986-1999) at Memorial Sloan-Kettering 
Center (New York, NY, USA), 728 free flaps were performed in 698 patients. 
The center managed to perform 92% of all head and neck reconstructions 
using only four donor sites: the radial forearm, fibula, rectus abdominis and 
jejunum. In the oral cavity, the radial forearm flap was used in 75% of the 
cases and also in the midface or hypopharyngeal regions it was used on a 
regular basis (31-38%)(50). While most centers still seem to favor the radial 
forearm flap for most oral reconstructions, Lutz reports good outcomes when 
using the anterolateral thigh flap as a primary means of reconstruction, but 
does not differentiate between regions in the presented study. During a 4 
year period (1999-2003) 2587 flaps were used at Chang Gung Memorial 
Hospital (Taipei, Taiwan), 1315 of which were fALT flaps (50.8%), 425 
forearm flaps (16.4%) and 407 osteoseptocutaneus Fibula flaps (15.7%). 
Using only these three flaps, 83% of all head and neck reconstructions could 
be performed(51).  
During our study, the majority of our patients (20/25) were treated with a 
radial forearm flap, known to be the workhorse of free flap transfer in the 
oral cavity. In other patients, the anterolateral thigh flap (4/25) or fibula flap 
(1/25) were used. 
 
4 Discussion 
54 
 
4.2 Free flap survival and salvage 
Survival rates for free flap transfers are reported to be as high as 95,0% - 
98,8% by the most experienced centres worldwide and several studies with 
large numbers were published in the recent years(24, 25, 49, 52, 53). Back in 
1998, Hidalgo published results from a retrospective 10 years spanning 
study which included 716 consecutive free flaps over 10 years in 698 
patients, 69% of which were located in the head and neck region. The 
overall flap survival rate was reported to be 98%(53). In 2007, a study 
including a total of 1142 free tissue transfers was published by Chen. Again, 
most of the transfers were used in the head and neck region and the overall 
complete flap survival rate was 96.4 percent (25). In Bui`s large study, also 
published in 2007, 1193 free flaps were examined - the largest subregion 
once more in the head and neck with 74 percent. The overall flap survival 
was reported even higher with 98.8%(24). 
While the above studies report their survival rates for all regions and do not 
individually list rates for the head and neck regions, specific reports have 
looked into this region to see if there are differences or specific problems. 
Dassonville reviewed 213 free tissue transfers between 2000 and 2004. With 
93.4% the overall success rate was reported a little lower than in the studies 
covering all body regions. Recipient site complications occurred in 20.9% of 
all patients, the most common of which were infection in 21 cases, 
associated with a strong correlation to salivary fistula formation. The second 
most common complication was neck hematoma requiring drainage in 16 
cases(54). Comparable results were presented by Haughey, who reported a 
success rate of 95 percent. In his series of 241 flaps in 236 patients, 10 total 
and 3 partial flap losses were reported(49). Nakatsuka published a very 
impressive study including 2372 free flaps in 2301 patients during a period 
of 23 years, beginning in 1977. With 4.2% total and another 2.5% partial 
flap necrosis, the overall flap survival rate was 93.3%(55). 
Another study focusing on free flaps in the head and neck by Suh examined 
400 free tissue transfers in 288 patients by a single senior surgeon between 
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1995 and 2002. Of these, only 0.8% of total flap failures were reported, 
presenting one of the lowest failure rates in the world(56). 
In our study, all flaps healed in well and no flap was lost, not even partial 
necrosis was observed. Given the rather small case number presented in this 
feasibility study we lie within the expected reach and with increasing 
numbers flap failures would most probably be observed. Also, in our study 
all procedures were performed by only one experienced surgeon. 
When a flap is at risk of failing, immediate salvage surgery has to be 
performed. Flap re-exploration is a common procedure in free tissue transfer 
with rates between 4.8 to 16.0 percent within the first 7 days following 
surgery(24, 25, 49, 57, 58). Brown et al. reports a comparably high surgical 
revision rate of 16%, but his data encompasses patients from 1992 to 1998 
and is thus one of the oldest studies in this field(57). When taking into 
account even larger and more recent studies, the overall re-exploration rate 
seems to be considerably lower. However, free flaps in the head and neck 
region seem to be slightly more prone to complications with need of 
exploration than other regions, according to Bui, and accounted for the 
highest revision surgery rate (6.6% compared to 6.0% total)(24). Wu 
presented a study that ran over 20 years and included 1918 patients with a 
total of 2019 transplanted free flaps exclusively in the head and neck region 
and showed an even higher revision rate of 9.9%(59). 
The rates of successful salvage surgery vary greatly between studies and 
range from 32% to 73%(53, 57, 59-62). In up to 15% of cases, however, no 
pathologic findings concerning the flap perfusion are found during revision 
surgery according to Bui et al.(24). Because the patient is then exposed to the 
risks of surgery and the associated anaesthesia unnecessarily, the rate of 
negative explorations should be minimized. 
A total of 6 revisions in five patients were performed in course of our study. 
Two of them, however, were performed directly during the initial surgery 
before the patient left the OR. So with three out of 25 patients to undergo 
revision surgery (12%) – one of them twice – within the first postoperative 
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week our rate seems to be comparable to current literature(59). On the other 
hand, all revised flaps eventually healed in without any partial or total flap 
loss resulting in a salvage rate of 100 percent. There were 33% percent 
(2/6) of negative re-explorations, which is rather high in comparison to 
current literature. 
Failures of free transplants are almost exclusively caused by an impeded 
blood supply. Generally in free flap transfer, venous complications occur way 
more often (54-93%) than arterial thrombosis (7-23%)(53, 57, 61, 62). All other 
possible reasons like mechanical stress, hematoma, infection or fistula 
formation only play a secondary role and usually present themselves later 
and can themselves induce thrombosis, as has been shown by Hyodo(60).  
In the head and neck, venous and arterial causes for reexploration attribute 
for approximately the same percentage (38% venous, 35% arterial), 
followed by bleeding (14%) and hematoma (13%) (59). 
When arterial thrombosis is present, flap survival rates are generally worse 
than in flaps which suffer from venous thrombosis. This is mainly because 
salvage rates vary between both groups. While total salvage of flaps with 
venous congestion can be achieved in 54-69%, the outcome is much more 
unfavorable when arterial malperfusion is present and only 15-51% rescued 
(55, 58, 60). Again, Wu presents precise data for the head and neck region and 
shows that for venous congestion a salvage rate of 74% can be achieved 
while only 50.7% of arterially compromised flaps could be successfully 
salvaged(59). 
Both intraoperative revisions in our study showed arterial problems and lead 
to the arterial anastomoses being revised. Of the four patients to undergo 
true revision surgery, only two (50%) showed pathologic findings – 
hematoma in one case and venous pedicle thrombosis in the other. Our data 
may imply a rather high rate of arterial problems (2/4 or 50%) compared to 
venous impairment (1/4 or 25%), in contrast to literature. A possible 
explanation might be our inclusion of intraoperative findings from the initial 
procedure, before the patient even left the OR, which no other study did. If 
4 Discussion 
57 
 
only the postoperative period is to be looked at in accordance to literature, 
there were no arterial complications during our study. A reason for low 
venous congestion rates might be found in our routine use of venous 
mechanical anastomotic coupler devices (vMACDs), which were used in each 
patient. Various studies showed significantly lower venous thrombosis rates 
when using vMACDs in comparison to using conventional hand sewn 
anastomoses. In reconstructive breast surgery, the usage of vMACDs 
decreased the venous thrombosis rate from 3-10 percent to as low as 0.6 
percent (63). Similar results have been presented in the head and neck region 
(64, 65).  
Time of presentation of complications is a critical factor which largely 
influences the postoperative monitoring regime. The vast majority of all free 
flap complications presents itself within the first 24 hours postoperatively. 
Up to 82.3 percent can be identified within the first day, another 8.8 percent 
during the next and finally 4.4 percent on the third day. After the third 
postoperative day, complications are much less likely to occur (25). Since up 
to 95.5 percent of all flap failures develop during the first 72 postoperative 
hours, this period is the most important and frequent monitoring is crucial(31, 
61). 
In our study, all patients who showed signs of impending flap failure 
presented these within the first 24 postoperative hours. Immediate revision 
during the initial surgery was performed in two patients (LMU 6 and LMU 23) 
and both showed arterial problems that could be solved by renewal of the 
arterial anastomosis. In the later revision surgeries hematoma and venous 
congestion were found in two patients (LMU 13 and LMU 19), but in two 
other patients no definitive intraoperative pathology could be determined 
and the perfusion of the anastomoses was normal (LMU 23 and LMU 25).  
In 1996 Kroll reported, that salvage after the third postoperative day is 
unlikely as all of the revised flaps were unsalvageable irrespective of the 
cause of thrombosis(61). In analogy, Yu showed a significant difference in 
successful salvage rates between flaps revised within the first 72 
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postoperative hours (61%) and after (13%)(66). In the following years, other 
studies showed success in flap salvage even later, although the probability is 
much lower.   
When salvage surgery is performed, the outcome depends on how much 
time lies between detection of impending flap failure and begin of the 
salvage surgery – it was shown that salvaged flaps were revised significantly 
earlier than failed flaps(24). 
After revision surgery, all six flaps healed in well and the further hospital 
stay of the respective patients was uneventful, irrespective of cause of 
failure or timing of operative revision. All patients in our study were revised 
within the first 24 postoperative hours immediately after signs of impending 
flap failure were present. No signs of impairment were observed after this 
early postoperative period. 
4.3 Postoperative monitoring techniques 
To date, after over 50 years of free flap transfer, various methods of 
postoperative monitoring have been described and tested. Gold standard 
today is still clinical judgment of an experienced microsurgeon as it is still 
the most reliable method of monitoring. This includes checking for changes 
in appearance, color, texture, temperature and capillary refill. Pinprick 
bleeding can provide further information and help determining, whether an 
arterial or a venous problem is more probable. The use of hand-held acoustic 
Doppler probes is often considered an adjunct of conventional monitoring. 
These checks should be performed regularly and frequently within the first 
72 hours following surgery, although there are no guidelines and not all 
centers use this regime routinely.  
In 2005, Jallali published results from a survey among plastic surgery units 
in the UK that showed that only 28 percent of all units perform regular 
clinical monitoring for more than 72 hours postoperatively. The majority 
cover between 48 and 72 hours and only 5% of all units refrain from routine 
clinical assessment beyond the first postoperative day. Frequency of checks 
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also varied between units, but the most frequent regimen was hourly for the 
first 24 hours, 1-2 hourly for the following 24 hours and every 4 hours after 
the first 48 hours(31). 
The efficacy of clinical monitoring (including the use of hand-held Doppler 
probes) was shown by Disa in 1999, when vascular compromise in non-
buried flaps was usually identified within the first 48 hours postoperatively 
and lead to flap salvage in 77 percent and overall success rate of 98.2 
percent. These non-buried flaps were monitored by clinical observation, 
Doppler examinations and pinprick testing. In contrast, buried flaps showed 
significantly worse outcome with overall success of only 93.5 percent due to 
very late (generally > 7 days) and therefore unsalvageable complications. 
These complications may develop much earlier, but are very hard to be 
detected. The author assumes the reasons in limited monitoring possibilities 
in these flaps, which could only be assessed by Doppler examinations(67). 
As mentioned before, our unit performs these clinical and Doppler probe 
checks hourly for the first 72 hours, then every 2 hours on day 4 and 5 and 
then once daily (clinical checks only) within the first 2 weeks 
postoperatively. To overcome restriction in monitoring of buried flaps, we 
routinely externalized a part of the flap as a so coalled “monitor” to allow for 
direct and easy inspection - as was also recommended by Disa in his 
aforementioned publication(67). Other studies also showed how using an 
externalized distal skin paddle can help in identifying impending vascular 
compromise earlier in buried flaps and raise the salvage rate to 67%(28). The 
method has been put forward by Byun(68) and Iwasawa(27) in the 1990s for 
free forearm flap transfer. However, the described method went along with 
increased risk of fistula formation due to an additional suture and a number 
of false positive readings due to microvascular compromise of the distal 
island flap. Nonetheless, it provides an important additional tool for the 
evaluation of buried flaps, which would otherwise not be routinely 
examinable without the use of endoscopes (29). 
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To supplement clinical judgment, a number of methods have been put 
forward in the recent decades. The most commonly used is the hand-held 
acoustic Doppler probe that can reliably identify arterial and venous flow 
signals through intact soft tissue. It is based on the Doppler principle and 
can use the frequency shift of moving objects or fluids like blood and make 
the flow audible. The abundance of vessels in the head and neck region can 
complicate the identification of the pedicle vessels. Marked postoperative 
swelling, hematoma or emphysema may drastically reduce the value of the 
examination, as a regular flow might be present but undetectable due to 
physical limitations or displacement. The initial investment in the reusable 
hand-held Doppler probe is only several hundred dollars per device and they 
can be obtained from multiple manufacturers. 
Apparent restrictions of the method lead to the emergence of several 
additional monitoring techniques (29). 
An improved and slightly more advanced method is the use of Colour 
Doppler Imaging (CDI) with its widespread use throughout many medical 
fields from angiology, cardiology to different surgical specialties. Apart from 
flow, it can also determine the relative direction of the flow in relation to the 
probe. To achieve best results, an experienced examiner is required(69). A 
further variation is the so-called Power Doppler Imaging (PDI) mode, which 
is even more sensitive to low flow velocities and can even show tissue 
vascularity, but yields no information about the direction of blood flow. Use 
of PDI for free flap monitoring in the head and neck has been demonstrated 
and is considered to be a welcome adjunct to CDI(70). Recently, contrast 
agent based assessments like Contrast Harmonic Ultrasound Imaging (CHI) 
or Contrast Enhanced Ultrasound Imaging (CEUS) have been introduced as 
further refinements of previous systems and seem to detect even minimal 
flows and are considered to provide valuable additional information on flap 
perfusion to a depth of 3cm maximum(71, 72).  
These methods all suffer from the same problems: neighbouring vascular 
structures could be mistaken for the pedicle vessels – a problem which can 
4 Discussion 
61 
 
be worsened due to postoperative swelling and bleeding and a possible 
displacement of the pedicle.  Technical improvements like CHI or CEUS, 
however,  might be able to identify the anastomosis by using sonographic 
contrast agents (e.g. Sonovue™) and thus overcome this problem(71). 
Another problem that could be encountered with the above mentioned 
systems is based on the fact that in the early stage of venous congestion, 
the arterial flow may still be normal while microcirculation is already 
impaired. There is a huge array of colour duplex systems available by many 
different manufacturers (e.g. Siemens, GE, Toshiba) and - depending on the 
demanded specifications - they cost between $30,000 and $225,000(73). 
Nonetheless, most units will employ at least one capable colour duplex 
ultrasound and most probably no new devices have to be purchased for 
mere use in flap monitoring.  
Laser-Doppler flowmetry has been introduced in the 1980s and allows for 
measurement of blood flow velocity using the Doppler principle in 
conjunction with light (not sound)(74). Tissue is illuminated with a coherent 
laser light of 820nm wavelength and a probe then collects the backscattered 
light and its frequency shift, which can be used to calculate the velocity of 
blood flow. It was shown, that Laser-Doppler flowmetry can detect vascular 
problems prior to clinical assessment and seem to be able to safely identify 
vascular compromise. The probe itself is rather flat like a spatula and use in 
the head and neck region has been proved feasible for non-buried flaps(75). 
Although the probe is capable of delivering continuous online measurements, 
it is still only applied at specific intervals and not a continuous monitoring by 
definition. Continuous monitoring can be achieved though, by sewing the 
probe temporarily to the flap and due to marked differences in flow 
alteration, venous and arterial compromise can often be differentiated. While 
a marked and rapid or almost instant decrease in flow velocity is 
characteristic for arterial compromise, venous occlusion shows a continuous 
and significantly slower decrease (76, 77). Prices begin at $5460 for the 
monitoring box and probes range upwards of $1015, but can be reused in 
least ten cases or for six months before they need to be replaced(73). 
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All of the presented devices are for use on the flap surface only and usually 
do not allow for continuous monitoring in a regular clinical setting. In 1988, 
Swartz presented his results from an experimental and clinical study in 
which he used an implantable ultrasound Doppler monitoring device with a 
20MHz wavelength. Initially, the probe was attached to the pedicle artery 
distally of the anastomosis and allowed for precise and immediate detection 
of reduced arterial flow due to occlusion. There were a few cases (2/63) that 
underwent unnecessary revision due to dislocation of the probe and one 
malfunction (1/63) was reported, which could be resolved prior to re-
exploration. The device failed to detect venous occlusion rapidly, although 
specific changes could be identified in retrospective(78). The method has 
been further refined by attaching the probe to the vein instead of the artery 
and thus lead to a markedly improved detection of flap failure (16/16) and a 
high salvage rate of 75% (12/16) in one study. As well, there were no more 
negative re-explorations based on the misinterpretation of Doppler signals. 
Another advantage is the possible continuous use for monitoring with a very 
quick response time to changes(79). The method has since then been subject 
of many studies which proved its worth in postoperative monitoring(80-82). 
In 2009, Rozen et al. published their results of a study, where clinical 
monitoring was compared to continuous implantable Doppler probe 
monitoring alone in regard to overall flap survival and salvage rates. 
However, no significant differences between those two methods could be 
found, placing the method next to clinical judgment of an experienced 
surgeon, the actual gold standard(83). The disadvantages on the other hand 
are also obvious: the probe itself can be detached from the pedicle and thus 
fail to measure correctly and finally lead to an unnecessary surgical revision. 
Since it is attached to the vessels, it is basically a pedicle monitoring. 
Changes to mircovascular flap perfusion might be present and lead to partial 
necrosis while blood flow in the vessels is normal and might thus be 
overlooked.  Of-the-shelf systems  (e.g. by Cook Medical, Bloomington, IN, 
USA) are available. The method itself is invasive and therefore might expose 
the patient to unnecessary risks, but no major complications with the used 
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devices have been reported yet, so that it can be considered a safe 
monitoring method. The costs amount to $3100 for the monitoring box and 
$412 for each disposable single-use probe(73). 
Since 2010 a novel device - the GEM Flow Coupler was introduced (Synovis 
Micro Companies Alliance, Inc., Birmingham, Alabama, USA). It combines a 
regular venous mechanical coupling device with an implantable Doppler 
probe and makes monitoring the venous anastomosis easier. Clinical studies 
have shown similar results when compared to the conventional Cook-Swartz 
Doppler(84, 85). A flow coupler monitor costs 2790 €, each single flow coupler 
unit 795 €, whereas a regular single coupler (without the implantable 
Doppler probe) costs only 210 €. Although this might seem expensive at 
first, the higher price for the combined device might even reduce costs of 
the entire procedure by saving OR time, since the correct placement of the 
Doppler probe at the anastomosis as a separate and usually difficult as well 
as time-consuming step is omitted(84). 
In contrast to these pedicle-focused methods stand those, that are meant to 
register changes in microcirculation of the entire flap and not only within the 
larger vessels.  
Measuring tissue temperature, infrared thermography has been successfully 
applied and may be a useful, noninvasive method after free flap transfer to 
the outer body surface(86, 87). Thereby, the surface temperature has been 
shown to correlate with the tissue microcirculation. In order to work 
properly, a temperature difference to a reference tissue is needed. The 
method thereby may even be able to differentiate between arterial and 
venous compromise (88). It probably loses its relevance in the UADT though, 
where the temperature of the flap always approximates the body 
temperature independently of its perfusion, although there are no studies on 
that subject(82). The controversy about the method’s value is still ongoing, 
since it reportedly failed to detect flap compromise in some reported 
cases(89). 
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Another method is perfusion weighted MRI , that can identify changes in 
tissue perfusion even in deeper layers of the flap or completely buried flaps. 
It encompasses the entire engrafted tissue and not only its surface, and 
allows precise prediction of flap viability. Obviously, an MRI tomograph is 
required, the patient has to be mobile or be moved – which can be 
cumbersome and even dangerous in some instances - and is time and cost 
intensive as it takes up to 30 minutes and an average MRI tomograph costs 
around one million dollars and subsequently the single evaluation can cost 
thousands of dollars(90).  
Metabolic monitoring can be achieved by microdialysis when biochemistry of 
the flap is examined. A catheter is positioned during surgery and later a 
physiologic fluid is irrigated that equilibrates with the interstitial fluid around 
it. This fluid is then analysed for marked changes like falling glucose 
concentration or rising lactate to pyruvate ratio that can be indicative of 
arterial malperfusion. Venous occlusion is identified by increasing glycerol 
levels. In a laboratory setting, the method was shown to be working and has 
already been adapted for use in patients, especially with intraoral 
reconstruction(91). Unfortunately, the analysis of the fluids takes up to 30 
minutes of time, though, and for maximum flap survival, time is essential(82). 
The costs consist of a high initial investment of almost $52,000 for the 
monitoring and analysing unit alone. Per each flap, additional costs for 
catheters, reagents and consumables sum up to around $570.  
Oxygen-saturation of the flap tissue can be measured by tissue 
spectrophotometry or spectroscopy using the absorption of white light by 
oxygen-saturated haemoglobin and its “colour”. It determines the average 
oxygen saturation and haemoglobin concentration in a given examined 
volume of tissue. The method is non-invasive and the probe can be used 
covered in a sterile cover sheath, if necessary. Rising haemoglobin levels in 
the flap are indicative of venous occlusion, and falling levels of oxygen-
saturation can mean arterial compromise(92). The method lends itself to 
combination with simultaneous laser flowmetry and then allows for a precise 
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assessment of flap perfusion(75, 93, 94). According monitoring devices are 
commercially available, e.g. the O2C system (Oxygen-to-see, LEA 
Medizintechnik GmbH, Gießen, Germany). A monitoring box usually costs 
around $16,500 and an additional $150 are needed for each disposable 
sensor. 
Another method for flap monitoring are fluorescence angiographies following 
application of contrast agents such as Fluorescein or ICG. 
None of these advanced and objective methods has reached wide-spread 
acceptance so far, however. While frequent clinical checks and simple 
Doppler examinations are performed by approximately 80% of all surgeons, 
less than 10% use advanced monitoring methods like the implantable 
Doppler probe(23). 
Previous studies showed that fluorescence angiographies correlate well with 
tissue perfusion and are able to precisely predict necrosis in free and 
pedicled flaps. In 1977 the first experiences with Fluorescein-based tissue 
angiography in arterialized flaps were published and it was shown that it was 
able to accurately predict necrosis within a distance of 3-5 mm(95). 
Encouraged by this study on 285 pedicled flaps, the method attracted lots of 
attention in the 1980s and early 90s(96), but was subsequently abandoned 
for flap monitoring because of the severity of possible side effects(97) as well 
as unfavourable pharmacokinetic properties of the dye and the possibility of 
erroneous interpretation of marginal fluorescence. Today, there are still 
plenty of other indications for Fluorescein use in other medical fields like 
ophthalmology (32, 33). 
Indocyanine Green (ICG), another fluorescent dye, has been in clinical use in 
different fields and for various indications since the 1960s(35) (e.g. assessing 
cardiac or hepatic function as well as visualization of choroidal vasculature) 
until now and is internationally approved. ICGs pharmacokinetic properties 
are more favourable for the purpose of flap monitoring than Fluorescein’s as 
it has a high affinity to plasma proteins and thus stays strictly intravascular. 
ICG is quickly degraded in the liver with a half-life of 3-4 minutes and is 
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then eliminated through the biliary system and not subject to enterohepatic 
recirculation. This makes it ideal for repeated administration, as it is almost 
completely eliminated from the blood after 20 minutes(43). So far, there have 
been no reports of severe adverse effects, although anaphylactoid or 
anaphylactic reactions are possible (with an incidence of approximately 
1:40000(44, 98)) as well as reaction to the iodide in the dye. The use of ICG is 
considered to be very safe and only few contraindications exist(99). 
In 1995, Indocyanine Green was first successfully applied in an experimental 
rat model with axial flaps and showed high resolution images of superficial 
tissue perfusion(41). After the potential for flap monitoring was seen, further 
experimental studies were performed and using computer-aided calculations 
predicting flap necrosis was possible for the first time(42). Clinical trials 
confirmed the ability of the method to predict flap necrosis and even 
superficial epidermiolysis on the flap surface(100).  
An example of a no longer commercially available device for surface ICG 
fluorescence angiography is the IC-View® System, which offered an 
integrated solution with near-infrared excitation light and a filtered video 
recording system (Pulsion Medical Systems, Munich, Germany). The costs 
depend on the needed hardware, but usually an infrared sensitive camera 
with appropriate optical filters and a near-infrared light source should suffice 
and cost no more than a few thousand dollars in a non-endoscopic setting. If 
use with an endoscopic unit is desired (for example for observing 
reconstructed areas within the upper aerodigestive tract), according to Karl 
Storz GmbH (Tuttlingen, Germany), a complete initial setup consisting of 
light source, NIR optimized camera head and controller, endoscopes with 
build in filters and video recording system would cost around 30,000€. Of 
course this equipment can be used for conventional endoscopic examinations 
or surgery as well, and would thus alleviate the initial investement. Also, 
existing gear like HD camera heads which already are NIR capable can be 
further used. At present (December 2015) there are several ICG-capable 
cameras available from Karl Storz (Tuttlingen, Germany), e.g. the TRICAM 
PDD-3-Chip Camera (20221037), the Image1 H3-Z FI 3 Chip-ICG-FULL-HD-
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Camera (22220085-3) and the Image1 H3-Z FI SPIES 3-Chip-FULL-HD-
Camera (TH 102). They are used in combination with a D-Light P SCB light 
source (20133701-1) and a TRICAM control unit or the IMAGE 1 HUB HD 
SCB camera controller (22201011-102), respectively. There are two 
endoscopes with build-in filters available – the HOPKINS 0° (26003 ACA) 
and HOPKINS 30° (26003 BCA). Both are 10mm in diameter and the former 
offers a straight forward view, while the latter provides a 30° angle. 
A single dose of ICG runs at approximately 50€. 
4.4 ICG Imaging for assessing patency of anastomoses 
Holm et al published two papers, that showed how a modified operational 
microscope with ICG capability could lead to better results regarding overall 
salvage and failure rates. Shortly after anastomosis the vessels were 
examined by ICG angiography through the microscope that provided the 
surgeon with a real time assessment of patency of the arterial and venous 
branch of the flap. Integration of the needed filters into the optical path of 
surgical microscopes is meanwhile possible and commercially available, and 
has been shown to be useful and time-saving, as directly after anastomosis 
a test of patency is possible without removing the microscope(101, 102). 
When pathologic findings (11/50 cases) lead to immediate intraoperative 
revision (n=3), flap survival was 100%(101).  
As an additional instrument for determining need of re-exploration and 
probable cause of flap failure, Holm described the intrinsic transit time (ITT) 
of the flap – the time needed for the ICG fluorescence to travel from the 
arterial to the venous anastomosis – as a predictive factor towards 
postoperative complications. Patients with an uneventful postoperative 
course showed significantly lower ITTs (median: 31sec) compared to 
patients with flap loss or early revision (median >120sec)(103). Holm 
suggested the method could be valuable in the re-exploration situation to 
assess patency of the pedicle and the anastomoses and possibly avoid 
unnecessary manipulation of an intact vessel. The intraoperative findings 
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could be compared to the video material obtained in the initial surgery, 
especially, when the revising surgeon was not present at the first procedure 
(40, 104). Studies have proven the value of the method and its very high 
sensitivity (100%) and specificity (86%) when applied to the anastomosed 
pedicle vessels (104).  
The method is not a monitoring technique, but a valuable tool to evaluate 
patency of the anastomoses intraoperatively before closing the neck or in a 
revision situation. It can therefore not be compared to the presented ICGA 
which does not assess pedicle patency, but surface perfusion of the flap. 
4.5 Study Summary 
In the presented study, the use of the dye and endoscopic devices was easy 
and non-problematic. Preparation time including dilution of ICG in aqua and 
assembly and setup of the endoscopic equipment took about 5 minutes. The 
period of actual measurement was about 2 minutes in most cases, including 
WL imaging prior to and after the proper ICG angiography. In patients that 
were still under general anaesthesia in the OR and when a stand for the 
endoscope was used, the recorded sequence was up to 5 minutes long. 
Sedated and fully awake patients alike tolerated the examinations very well 
and there were no adverse reactions or injuries. After that, it took about 5 
minutes to save and record the data and disassemble the equipment for 
transportation and storage. Overall, a single measurement could be 
performed in less than 15 minutes.  
Since this study was only intended to prove the feasibility of an endoscopic 
ICG-perfusion measurement, only 25 patients were to be included. To our 
knowledge, this is the first study using endoscopic ICG angiography in the 
head and neck region. In the course of the study, 78 ICG angiographies – 
including six additional measurements after revision in five cases - were 
performed. The majority of all patients could be examined according to the 
study protocol without any problems (24/25). Unfortunately, in one case, 
LMU 05, the flap could not be completely seen endoscopically in the follow-
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up period due to massive postoperative swelling without risking to inflict 
damage to the transplant. Since this shows an obvious limitation of the 
method, the patient was not excluded from the study. Probably, the use of 
an angled or flexible endoscope instead of the forward looking one would 
have been beneficial in this case, but was not available in the study setting. 
As mentioned before, there are two 10mm endoscopes available at Karl 
Storz - the HOPKINS 0° (26003 ACA) and HOPKINS 30° endoscope (26003 
BCA).  
It is already also possible to use conventional endoscopes with a snap-in 
ICG-Filter, though. The drawback of this method is, that a prior identification 
of the flap in white light would have to be done without the filter since it 
blocks most of the ambient light. Through insertion of the filter, 
displacement is probable, that would thus lead to an erroneous depiction and 
examination of the flap. Karl Storz GmbH has meanwhile introduced new 
endoscopes with integrated changeable filters, which allow for instantaneous 
switching between white light and fluorescence imaging and are even easier 
to use. 
A problem we encountered in the first patient is that with the existing IC 
Calc software, a reliable measurement is not possible, if there is a lot of 
movement of the endoscope relative to the ROIs. This issue could be 
overcome by implementing a tracking software, which is able to follow 
defined ROIs. Outside of the study our department performed experimental 
testing that enabled simultaneous white light and ICG fluorescence imaging 
using a single standard 3-chip camera head. Reflected blue light was filtered 
from the camera and later digitally reconstructed to recreate a “pseudo 
white light” image with only little impact on colour perception. Fluorescence 
could be displayed in a second window at the same time and changed to 
false colours, if desired. Implementing a motion tracking system proved 
helpful and allowed for more precise calculations(105). 
For further advancement of the presented ICGA method, new evaluation 
software has to be designed, since IC Calc in its current form is no longer 
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supported by the manufacturer Pulsion Medical Systems and development of 
a new analysis program is not in planning according to representatives of 
the company.  
The method of endoscopic ICG angiography is simple and easy to learn, 
since the used Karl Storz system is only a modified version of the normal 
endoscopic equipment and the additional functions are seamlessly integrated 
in the existing gear. OR personnel could be quickly trained to safely and 
correctly use the ICG angiography equipment, so that it could be made 
available even at nights in emergency situations.  
In total, six surgical revisions were performed. In two of those, the patients  
were only examined AFTER re-exploration, as time was pressing and none of 
the study examiners were present at the time. These two cases are 
therefore not helpful for an early evaluation of the value of the method 
presented. Nevertheless, those two flaps then postoperatively showed 
“normal” ICGA behaviour after revision and healed in well. In a further two 
cases (LMU 6 and LMU 23), ICGA was performed prior to surgical revision 
due to a clinical indication, and the malperfused arterial anastomoses were 
successfully revised. In these cases, the on-line angiography showed that 
ICG uptake was significantly delayed and maximum fluorescence intensity 
remarkably lower than it was in prior measurements of patent flaps. In the 
last two cases that underwent revision surgery due to a retrospectively false 
clinical indication (LMU 23 (second revision) and LMU 25), ICGA was also 
performed before revision surgery and had shown subjectively “good” 
perfusion. Especially in LMU 25, an extremely obese patient with 130 kg and 
additional cutaneous emphysema, where clinical signs of malperfusion were 
equivocal and conventional monitoring with a hand-held Doppler probe could 
not be performed, the ICGA could have made the additional surgical 
procedure unnecessary retrospectively. In conclusion, a total of two 
unnecessary operations could have been avoided if the results from the 
ICGA measurements would have had an influence on the indication of a 
surgical revision (outside of this study protocol). 
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The off-line evaluation of the data objectified the subjective impressions: the 
fluorescence index (FI; relative maximum of fluorescence intensities) was 
0.33 and 0.37 for the flaps with impaired perfusion and 0.84 (0.73 – 0.93) 
for the revised flaps without pathologic findings and intervention. All other 
flaps showed an FI of 0.83 (0.60 – 0.96) directly after anastomosis and 0.88 
(0.68 – 1.00) 72 hours postoperatively. Since it can be assumed that ICG 
angiography corresponds with perfusion, as it correlates well with 
cardiovascular factors also in our study, the growing fluorescence index over 
time is most probably a sign of improving blood supply of the flap that 
comes from either consolidation of the anastomosis and improved pedicle 
patency, or the improvement of microperfusion over time. These results 
backup previous animal and clinical studies which presented a FI of 0.10 
(0.06-0.42) for complicated postoperative courses in patients and 0.87 
(0.07-2.26) for regular uneventful courses(42, 106). Since the study design 
was slightly different and we experienced no partial or complete flap losses, 
these values might not be fully comparable as there was no further 
information on how the regions of interest were defined by the interrogator, 
but add weight to our results. In contrast to these other studies, there was 
no overlap between the groups “revision needed” and any other. In order to 
define a threshold, we would like to suggest an FI of 0.50 as a value below 
which a revision should be strongly recommended. 
At the same time, the Perfusion index (relative gain of fluorescence over 
time) is also dependent on time after surgery and rises in a similar manner. 
But other than the fluorescence index, the perfusion index showed massive 
inter- and intrapatient variability. The PI was shown to scatter extremely 
depending on selection of the ROIs and is less reproducible within the same 
patient. When revision was necessary, the PI was 0.20 or 0.29; when the 
postoperative course was uneventful, it ranged from 0.21 to 1.06 following 
anastomosis. In our study, it overlaps in the area from 0.21 – 0.29 and does 
not as sharply discriminate between insufficient and patent transplants as in 
other studies(42, 100, 106, 107). A threshold of 0.25 was suggested to predict 
necrosis – a value that does not stand in accordance with our experiences, 
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since we found only one insufficient (50%, 1/2) and two of the patent (9%, 
2/22) flaps in the range from 0.20 – 0.25. We therefore favour the 
fluorescence index (FI) as the better marker, as there is a stronger 
difference (0.35 vs 0.86) and no overlapping, and it can be as easily 
determined.  
To compare different monitoring devices, Ihbler just recently presented two 
new tool for evaluation: the revision success rate (RSR = salvaged flaps / 
revised flaps) and the flap failure reduction rate (FFRR = (lost flaps without 
monitor / n) – (lost flaps with monitor / n). He then used both tools to test 
the efficiency of the implantable Doppler probe to find an RSR between 50% 
and 92.3% in the five large studies on the subject. The FFRR ranged from 
5.5% to 11.6%(108). When we apply these new tools to our admittedly small 
study collective, our results compare favourably with a RSR of 100% and a 
FFRR of 8.0%. 
A survey in our department, including ICGA videos and white light images of 
the flaps, showed the possible use of the method in clinical routine. When 
judgment is merely based on visible clinical aspect without other factors 
(e.g. pinprick bleeding), only 66.7% of poorly perfused flaps were indicated 
for re-exploration correctly, as opposed to 90.5% in ICG angiography. This 
is an improvement of 35.7 percent that is merely attributed to a change of 
method and could greatly improve overall flap results. Also, based on clinical 
aspect, 24.0% of the well perfused flaps were wrongly considered to have 
poor or bad perfusion, while ICG only lead to 11.9%. When assuming that 
flaps with a possibly impaired perfusion had to be immediately revised, ICG 
screening prior to surgery could possibly reduce the rate of unnecessary 
procedures by up to 50%. It is notable, that patent flaps were judged 
remarkably better (3.42 vs. 2.96) and compromised ones remarkably worse 
(1.60 vs. 2.20) in ICGA than in WL. This leads to a better separation of the 
groups, as under WL the subgroups lay less than one step from each other 
whereas in ICGA it is almost two steps. Of course, 21 raters are a very low 
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number and this may not be generalized, but still a trend may be recognized 
here, especially since the qualification of the participants varied greatly. 
By using the ICG angiography in an endoscopic setting, even hidden and 
deep flaps otherwise inaccessible for conventional monitoring could be safely 
evaluated in a time and money efficient way. Of course, buried flaps could 
not be examined since – by definition – there is no surface to be monitored. 
The method has shown itself to be a potentially valuable additional 
evaluation tool if ambiguous signs of malperfusion are present. Possibly the 
highest potential can be seen in performing preoperative ICG angiography 
before revision surgery, when clinical and advanced monitoring are 
equivocal. If ICG angiography shows good perfusion (e.g. FI>50%), 
exploration could possibly be postponed and the rate of negative 
explorations with its possible harm for the patient could be reduced. 
Obviously, this statement needs verification in a much larger clinical trial. 
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5 Summary 
The presented study is the first to examine the possible value of an 
endoscopic fluorescence perfusion measurement after free flap transfer in 
the upper aero-digestive tract using the fluorescent dye Indocyanine Green 
(ICG).  
25 patients who had free flap transfer were included in the study after 
obtaining informed consent. Each patient was to be examined three times: 
first shortly after anastomosis in the OR (0h), second after 24 hours and 
third after a total of 72 hours.  
The examinations themselves took approximately 2 minutes each. Total time 
including assembly and later disassembly of the endoscopic gear and 
dissolving and application of the dye was about 15 minutes. It could be 
performed by one single examiner. The costs of one dose of ICG run about 
50 Euros. 
In total, six surgical revisions were performed. In two of those cases, clinical 
signs of impaired perfusion were present directly after anastomosis and 
closure of the neck access but still in the OR, and the ICG angiographies 
(ICGA) showed unusually low uptake of fluorescence in the transplanted 
flap. Both had a revision immediately in the OR and both cases had arterial 
problems. After these were resolved, the repeated ICG examination then 
showed greatly improved uptake of the dye in comparison to the earlier 
ICGA. Two further cases showed clinical signs of flap failure during the later 
postoperative stay and were indicated for urgent revision surgery. The 
immediately preoperatively taken ICG angiographies did not show any 
impairment of flap perfusion. In both cases there were no intraoperative 
pathologic findings that lead to any revision of the anastomoses. Due to an 
urgent indication for revision in the last two revision cases, no preoperative 
ICGA could be performed. One suffered from hematoma and the other from 
venous congestion, both of which had to be revised. The postoperative 
ICGAs then showed normal findings. All the other patients showed 
uncomplicated courses. 
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Video sequences of all examinations were recorded and stored for later 
offline evaluation using a dedicated software. There, regions of interest 
(ROI) had to be determined for the flap, the surrounding tissue and a 
prefabricated fluorescence reference platelet. Processing of the data lead to 
introduction of two derived parameters of flap perfusion. First, the 
Fluorescence Index (FI) which directly compared absolute maximum 
fluorescence intensities of the flap to the surrounding tissue. Second the 
Perfusion Index (PI), which compares the gain of fluorescence over time. 
The FI appeared to be more reliable in detecting impeding flap failure and 
had better reproducibility than the PI. Also, FI is easier to determine, since it 
is influenced by less variables. 
Later off-line evaluation of the data suggests the use of the fluorescence 
index instead of the perfusion index. A recommended cut-off-value would be 
0.50, below which revision surgery should be strongly recommended. 
Possibly, values above 0.50 might justify a wait-and-see attitude with 
increased frequency of repeated ICGAs as long as no unequivocal clinical 
signs of malperfusion are present.  
In order to evaluate a possible value of on-line interpretation during the 
ICGA, a survey among 21 medical staff members with experience in 
postoperative free flap monitoring from nurses to attending head and neck 
surgeons was performed. White light and ICGA sequences of the same ten 
flaps were shown to them and they were asked for their judgement 
regarding patency of the flap and need of revision. There, vascularly 
compromised flaps were much more accurately identified in the ICG views 
than under white light conditions.  
In this limited number of patients, ICGA had a high predictive value in 
detecting flap malperfusion and was easily and quickly performed. The 
intraoperative, real-time perfusion angiography provides the surgeon with 
additional information that could lead to important therapeutic 
consequences, once ICGA is accepted as an adjunct monitoring method. 
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In two cases, we demonstrated correct identification of malperfusion of flaps 
via ICGA. In two other cases where surgical re-exploration was performed 
but no vascular compromise evident, ICGA showed patency of the flap 
preoperatively, while clinical judgment was ambiguous at best. Possibly, 
operative re-exploration could have been avoided if the results from the 
ICGA would have been considered for clinical decision making.  
So far, ICG angiography is just another adjuvant method to assess flap 
perfusion, but our experience shows a great reliability. With a wider range of 
endoscopes including flexible endoscopes and an advanced software that can 
track the ROIs relative to a reference’s position and produce on-line values 
for FI of the measurement, this method could be further refined.  
Even if ICGA should not be established as a routine postoperative monitoring 
method, it could be used as an additional source of information, when 
clinical signs or other conventional monitoring methods are equivocal. 
Reduced surface perfusion should endorse the decision for operative revision 
while a normal perfusion situation could also allow for a wait and see 
approach. 
Further studies with increased patient numbers are needed, though, to prove 
the definitive value of endoscopic Indocyanine Green Angiography beyond 
anecdotal value.  
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6 Zusammenfassung 
Die vorgestellte Studie untersucht zum ersten Mal den möglichen Stellenwert 
einer endoskopischen Fluoreszenz-Perfusions-Messung nach Transplantation 
eines freien Lappens im oberen Aerodigestivtrakt unter Verwendung des 
Fluoreszenzfarbstoffs Indocyanin-Grün (ICG). 
25 Patienten, die eine freie Lappentransplantation bekamen, wurden in die 
Studie eingeschlossen. Zuvor wurden sie aufgeklärt und erklärten ihre 
Einverständnis zur Teilnahme. Jeder Patient sollte insgesamt dreimal 
untersucht werden: zunächst nach der Anastomosierung im OP (0h), dann 
24 Stunden und schließlich 72 Stunden postoperativ.  
Die Untersuchungen selbst dauerten jeweils etwa 2 Minuten. Die Gesamtzeit 
inklusive Aufbau und späterem Abbau der Endoskopieausrüstung sowie 
Herstellung der Injektionslösung betrug ca. 15 Minuten. Ein einzelner 
Untersucher konnte die Untersuchung alleine durchführen. Eine Einzeldosis 
ICG kostet etwa 50 Euro. 
Insgesamt erfolgten sechs chirurgische Revisionen. Bei zwei dieser Fälle 
zeigten sich bereits unmittelbar nach Anastomosierung der Gefäße und nach 
Hautverschluss des zervikalen Zugangs noch im OP klinische Zeichen einer 
Minderdurchblutung und die ICG-Angiographien (ICGA) zeigten 
ungewöhnlich geringe Fluoreszenzzunahmen in den transplantierten Lappen. 
Beide Patienten wurden unmittelbar im OP revidiert und beide litten unter 
arteriellen Beeinträchtigungen. Nachdem diese revidiert worden waren, 
zeigten die wiederholten ICG Untersuchungen dann eine stark erhöhte 
Aufnahme des Farbstoffes im Vergleich zur Voruntersuchung. 
Bei zwei anderen Fällen mit klinischen Zeichen des Lappenversagens im 
weiteren postoperativen Verlauf wurde die Indikation zur dringlichen 
Revision gestellt. Die unmittelbar präoperativ erfolgten ICG Angiographien 
zeigten keine Einschränkungen der Lappendurchblutung. In beiden Fällen 
zeigten sich intraoperativ keinerlei pathologischen Befunde, die eine Revision 
der Anastomose erfordert hätten. 
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Wegen dringlicher Indikation zur Revision konnten bei zwei weiteren Fällen 
keine präoperativen ICGAs durchgeführt werden. Ein Patient litt unter einem 
Hämatom, der andere an einer venösen Thrombose, welche operativ 
revidiert werden mussten. Die postoperativen ICGAs ergaben dann 
unauffällige Untersuchungsergebnisse. Alle anderen Patienten hatten 
unkomplizierte Verläufe. 
Die Videosequenzen aller Untersuchungen wurden aufgezeichnet und für 
spätere Offline-Evaluation mittels spezieller Software aufbewahrt. Dazu 
wurden jeweils für den Lappen, das Umgebungsgewebe und ein 
vorgefertigtes Fluoreszenzstandard-Plättchen Regions of Interest (ROI) 
definiert. Die Weiterverarbeitung der Daten führte zu zwei abgeleiteten 
Parametern für die Lappendurchblutung: Erstens den Fluoreszenzindex (FI), 
welcher direkt die maximalen Intensitäten der Fluoreszenz im Lappen und 
Umgebungsgewebe miteinander vergleicht, und zweitens den 
Perfusionsindex (PI), der die Fluoreszenzzunahme der Gewebe abhängig von 
der Zeit nach der Injektion vergleicht. 
Der FI stellte sich als zuverlässiger heraus, wenn es darum ging, ein 
Versagen des Lappens zu erkennen und war besser reproduzierbar als der 
PI. Darüber hinaus ist der FI leichter zu bestimmen, da er von weniger 
Variablen beeinflusst wird. 
Die nachträgliche Offline-Untersuchung der Daten legt die Verwendung des 
Fluoreszenzindex anstelle des Perfusionsindex nahe. Eine Schwelle von 0,5 
scheint empfehlenswert, unterhalb welcher ein Revisionseingriff dringend 
angezeigt scheint. Möglichweise rechtfertigen Werte oberhalb von 0,5 eine 
abwartende Haltung mit vermehrten wiederholten ICGAs im Verlauf, solange 
keine eindeutigen klinischen Zeichen von Minderdurchblutung vorliegen. 
Um den möglichen Stellenwert einer sofortigen Live-Interpretation während 
der ICGA zu untersuchen, wurde eine Umfrage unter 21 medizinischen 
Mitarbeitern mit Erfahrung im postoperativen Monitoring von freien Lappen 
von Pflegekräften bis hin zu Oberärzten durchgeführt. Dazu wurden ihnen 
Weißlicht- und ICGA-Videosequenzen von denselben zehn Lappen gezeigt 
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und um eine Einschätzung bezüglich der Vitalität des Lappens und der 
Revisions-Notwendigkeit gebeten. Dabei wurden die Lappen mit 
Gefäßproblemen unter ICG-Sicht deutlich besser identifiziert als unter 
Weißlicht-Bedingungen.  
Bei dieser limitierten Zahl an Patienten hatte die ICGA einen hohen 
prädiktiven Wert, wenn es darum ging eine Minderdurchblutung des Lappens 
zu erkennen, und ist einfach und schnell durchzuführen. Die intraoperative 
Echtzeit-Perfusions-Angiographie stellt dem Chirurgen zusätzliche 
Informationen zur Verfügung und könnte zu entscheidenden therapeutischen 
Konsequenzen führen, sobald die ICGA als ergänzende Monitoringmethode 
anerkannt ist. 
Wir konnten in zwei Fällen zeigen, dass die Minderdurchblutung von freien 
Lappen mittels ICGA erkannt werden kann. In zwei weiteren Fällen, bei 
denen chirurgisch reexploriert wurde, ohne dass sich intraoperative eine 
Gefäßproblematik zeigte, zeigte die ICGA die Vitalität des Lappens, während 
die klinische Untersuchung diesbezüglich nicht eindeutig war. Möglicherweise 
wäre eine operative Reexploration zu vermeiden gewesen, wenn die 
Ergebnisse der ICGA in die klinische Entscheidungsfindung miteingeflossen 
wären. 
Bisher ist die ICG Angiographie lediglich eine weitere ergänzende Methode 
um die Lappendurchblutung zu beurteilen, sie zeigt aber in unserer 
Erfahrung eine große Zuverlässigkeit. Die Methode könnte mit einer 
größeren Auswahl an Optiken einschließlich flexibler Endoskope und einer 
weiterentwickelten Software, die die ROIs selbstständig in Abhängigkeit vom 
ICG Standard verfolgen und Echtzeitwerte für den Fluoreszenz Index liefern 
kann, weiterentwickelt werden. 
Selbst wenn die ICGA nicht als ein postoperatives Routinemonitoring 
etabliert wird, könnte sie als zusätzliches Kriterium dienen, wenn die 
klinische Einschätzung und andere übliche Monitoringmethoden sich 
widersprechen. Eine reduzierte Oberflächendurchblutung sollte die 
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Entscheidung zu revidieren forcieren, während eine normale Durchblutung 
auch ein abwartendes Vorgehen rechtfertigen könnte. 
Weitere Studien mit größeren Patientenzahlen werden jedoch nötig sein, um 
den endgültigen Stellenwert der endoskopischen Indocyanin Grün 
Angiographie über einen rein anekdotischen Wert hinaus zu zeigen. 
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8.2 Abbreviations 
ASR  age standardized rates 
BP  Blood pressure 
CDI  Colour Doppler imaging 
CEUS  Contrast enhanced ultrasound imaging 
CHI  Contrast harmonic ultrasound imaging 
ENT  Ear, nose and throat 
EU  European Union 
FI  Fluorescence index 
fALT  free anterolateral tigh flap 
fFF  free fibula flap 
FFRR  Flap failure reduction rate 
fRFF  free radial forearm flap 
HPV  Human Papilloma Virus 
HR  Heart rate 
ICG   Indocyanine Green 
ICGA  ICG (Indocyanine Green) angiography 
ICU  Intensive care unit 
IMC  Intermediate care unit 
ITT  Intrinsic transit time 
LMU  Ludwig-Maximilian-Universität, München 
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MAP  mean arterial pressure 
MRI  Magnet resonance imaging 
OR  Operation room 
PDI  Power Doppler imaging 
PI  Perfusion index 
ROI  Region of interest 
RSR  Revision success rate 
SSC   Squamous Cell Carcinoma 
TMF  Time until maximum fluorescence in the flap 
TMS  Time until maximum fluorescence in the surrounding 
TNM  Tumor-Nodes-Metastasis 
TUO  Time until onset of fluorescence 
UICC  Union for International Cancer Control 
WL  white light 
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